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TRPV6Approximately 20 of the 30 mammalian transient receptor potential (TRP) channel subunits are expressed by
speciﬁc neurons and cells within the alimentary canal. They subserve important roles in taste, chemesthesis,
mechanosensation, pain and hyperalgesia and contribute to the regulation of gastrointestinal motility,
absorptive and secretory processes, blood ﬂow, and mucosal homeostasis. In a cellular perspective, TRP
channels operate either as primary detectors of chemical and physical stimuli, as secondary transducers of
ionotropic or metabotropic receptors, or as ion transport channels. The polymodal sensory function of TRPA1,
TRPM5, TRPM8, TRPP2, TRPV1, TRPV3 and TRPV4 enables the digestive system to survey its physical and
chemical environment, which is relevant to all processes of digestion. TRPV5 and TRPV6 as well as TRPM6 and
TRPM7 contribute to the absorption of Ca2+ and Mg2+, respectively. TRPM7 participates in intestinal
pacemaker activity, and TRPC4 transduces muscarinic acetylcholine receptor activation to smooth muscle
contraction. Changes in TRP channel expression or function are associated with a variety of diseases/disorders
of the digestive system, notably gastro-esophageal reﬂux disease, inﬂammatory bowel disease, pain and
hyperalgesia in heartburn, functional dyspepsia and irritable bowel syndrome, cholera, hypomagnesemia
with secondary hypocalcemia, infantile hypertrophic pyloric stenosis, esophageal, gastrointestinal and
pancreatic cancer, and polycystic liver disease. These implications identify TRP channels as promising drug
targets for the management of a number of gastrointestinal pathologies. As a result, major efforts are put into
the development of selective TRP channel agonists and antagonists and the assessment of their therapeutic
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The selection of useful food and its effective digestion are essential
for survival. To accomplish this goal, the digestive tract possesses a
large array of molecular sensors and transducers to make the right
choice and guide the process of digestion by appropriate feed-forward
and feed-back mechanisms. The physiological task of the alimentary
canal is highly challenging because, depending on the nature of
ingested food, the gut needs to carry out programs with opposite
aims: digestion of food and absorption of nutrients and water, on the
one hand, and the elimination of toxins, antigens, pathogens and
indigestible waste, on the other hand. Research in the past decade has
143P. Holzer / Pharmacology & Therapeutics 131 (2011) 142–170revealed an elaborate system of molecular sensors serving taste,
analyzing the chemical composition of food, monitoring the motor
and secretory activity of the gastrointestinal (GI) tract, and detecting
adverse conditions in the lumen and wall of the alimentary canal.
Transient receptor potential (TRP) channels, so named after the role
they play in Drosophila phototransduction, take a prominent position
among these sensors and transducers in the digestive system. A
number of their implications in GI physiology and pathology were
discovered subsequently to the analysis of the mechanism of action of
pungent spices (Bandell et al., 2007; Holzer, 2008a).
The search for and the intake of nutrients are governed by the
appearance, smell and taste of food. There is anthropological evidence
that the adoption of cooking food has been a key feature in human
evolution (Wrangham & Conklin-Brittain, 2003; Wobber et al., 2008).
Alongwith cooking, mankind also learned that the taste of food can be
heightened by seasoning, and food prepared with the right mixture of
spices is one of themajor human pleasures. The chemicals responsible
for the gustatory and olfactory pleasures of spices are secondary
metabolites of plants (Max, 1992; Cromer & McIntyre, 2008; Vriens
et al., 2008). Recognition of the chemical qualities of spices must have
driven the co-evolution of TRP channels as appropriate sensors in the
animal kingdom. The functional implications of TRP channels are, in
the ﬁrst place, congruent with the strategy of plants to discourage
predators by the unusual sensory quality of spices. However, by
perversion of this principle, humans have learned to enjoy low doses
of those deterrent chemicals (Max, 1992). This argument is supported
by the fact that capsaicin is pungent for mammals, but not birds which
are supposed to help distributing the seeds of red pepper, given that
the avian orthologue of the TRP vanilloid-1 channel (TRPV1) lacks the
binding site for capsaicin (Jordt & Julius, 2002).
The implication of TRP channels in the sensation of deterrent
chemicals was ﬁrst heralded when, in 1997, TRPV1 (then named the
vanilloid receptor-1) was identiﬁed as the sensor for capsaicin at
the genetic and functional level (Caterina et al., 1997). Responsible
for the piquancy of red pepper (Capsicum spp.), the vanilloid
capsaicin in its pure form is one of the most painful chemicals we
know, yet is also widely used for food seasoning. TRPV1 was soon
joined by other TRP channels with unique transduction properties
relevant to chemo-, thermo- and mechanosensation as well as
sweet, bitter, sour, salt and umami taste sensation (Zhang et al.,
2003; DeSimone & Lyall, 2006; Huang et al., 2006; Bandell et al.,
2007; Kaske et al., 2007; Montell & Caterina, 2007; Vriens et al.,
2008; Ishimaru & Matsunami, 2009; Wu et al., 2010). In addition,
these molecular sensors can detect speciﬁc chemical entities in-
cluding unpleasant and/or painful toxins, whereby they subserve
chemesthesis, the chemical sense distinct from taste and smell
(Bandell et al., 2007).
Currently, some 30 different TRP subunit genes have been
identiﬁed in mammals, these subunits being grouped in 6 families
(Wu et al., 2010). Members of 5 subunit families, speciﬁcally of the
vanilloid TRP (TRPV), melastatin TRP (TRPM), ankyrin TRP (TRPA),
polycystin TRP (TRPP) and canonical or classical TRP (TRPC) family,
are relevant to spice sensing, chemo-, thermo- and/or mechanosensa-
tion (Table 1). The TRP channel subunits are made of 6 transmem-
brane domains with a pore between transmembrane domains 5 and 6
(Clapham et al., 2005; Wu et al., 2010). Functional TRP channels,
thought to be composed as tetramers of four subunits, are opened or
closed by conformational changes in the channel protein (Dhaka et al.,
2006; Bandell et al., 2007). TRP channels are only weakly sensitive to
depolarization but open in response to changes in temperature,
binding of ligands or other alterations of the channel protein
(Clapham et al., 2005; Matta & Ahern, 2007; Nilius et al., 2007; Wu
et al., 2010). The ion selectivity differs markedly among the family of
TRP channels, most of them being non-selective cation channels.
The objective of this article is to review the occurrence and
function of TRP channels in the digestive tract, with a particularemphasis on their roles in health and disease. To keep the wealth of
the available information in perspective, overview panels guide the
reader to keep track of the functional implications of TRP channels in
the alimentary canal (Figs. 1 and 2) and their associations with
disorders of the digestive system (Fig. 3). Alterations in their
expression and function in disease have raised enormous interest in
TRP channels being attractive targets for new therapeutic strategies in
gastroenterology. Accordingly, several TRP channel ligands have been
developed, and it is a further objective of this article to summarize and
discuss the pharmacological opportunities which TRP channel ligands
offer to gastroenterology (Fig. 4).
2. Expression and functional
implications of TRP channels in the digestive tract
2.1. General considerations
Although various TRP channels, notably TRPV1, TRPV3, TRPA1,
TRPM5 and TRPM8, enable humans to enjoy seasoned food, they
subserve a much wider spectrum of functions in the alimentary canal.
TRP channels survey the environment of the gut for a large variety of
chemicals and toxins that either come in with the food, are formed in
the GI tissue, are constituents of the digestive juice, are produced by the
GI microbiome, or are generated by tissue injury and inﬂammation
(Table 1). In addition, some TRP channels are involved in mechan-
osensation or can sense a speciﬁc range of temperatures. Apart from
their sensory surveillance function, TRP channels in the alimentary
canal are relevant to the control of membrane potential and excitability
of neurons, epithelial cells, muscle cells and interstitial cells of Cajal
(ICCs), play a role in Ca2+ and Mg2+ absorption, govern blood ﬂow,
pacemaker activity, motor activity, secretory processes and mucosal
homeostasis, and impact on the development of GI cancer.
In reviewing the functional implications of TRP channels in the
alimentary canal, 3 distinct roles come to light (Fig. 1). (1) TRP
channels operate as molecular sensors (detectors or primary trans-
ducers) of chemical and physical stimuli; (2) TRP channels play a role
as downstream or secondary transducers (or effectors) of cell
activation mediated by G protein-coupled receptors (GPCRs) or ion
channel receptors; and (3) TRP channels function as ion transport
channels responsible, e.g., for Ca2+ and Mg2+ homeostasis. Within
primary afferent neurons, translation of signals detected by TRP
channel detectors into effector responses is carried by two distinct
mechanisms: (1) by the local release of neuropeptides from the
peripheral ﬁbers of TRP-expressing afferent neurons, which causes
changes in local tissue function (Holzer, 1988; Maggi & Meli, 1988);
and (2) by transmission to the central nervous system resulting in
autonomic reﬂex responses and sensation.
2.2. TRPV1 channels
2.2.1. Occurrence of TRPV1 in the alimentary canal
The existence of TRPV1, the speciﬁc sensor for capsaicin, has been
envisaged more than 30 years ago, given that most pharmacological
effects of capsaicin have been attributed to a speciﬁc action on
capsaicin-sensitive primary afferent neurons (Jancsó et al., 1987;
Holzer, 1991; Szallasi & Blumberg, 1999; Szolcsányi, 2004). The role of
capsaicin-sensitive afferent neurons and, by indirect inference, the
distribution of capsaicin receptors have been traced with two
experimental paradigms: stimulation of afferent neurons by acute
application of capsaicin, and pretreatment of animals or tissues with
high doses of capsaicin (“capsaicin desensitization”) to defunctiona-
lize afferent neurons via excess inﬂux of Ca2+ following stimulation of
TRPV1. Capsaicin-sensitive nerve cells may even degenerate if, e.g., a
high dose of capsaicin is administered to newborn rats (Jancsó et al.,
1977) or micromolar concentrations of capsaicin are added to dorsal
root ganglion (DRG) cultures (Wood et al., 1988). Since the whole
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capsaicin-sensitive structure or function in its historical connotation
does not necessarily point to an implication of TRPV1. In addition,
capsaicin at higher concentrations can act on ion channels unrelated
to TRPV1 and on cellular structures lacking TRPV1 (Holzer, 1991) such
as ICCs (Choi et al., 2010). Treatment of adult rats with a neurotoxic
dose of capsaicin reduces the number of nodose ganglion neurons that
express TRPV1 and project to the stomach as observed 10 days post-
treatment. By 67 days post-treatment, much of the vagal afferent
innervation of the stomach is restored, mainly because of sprouting of
capsaicin-insensitive nerve ﬁbers (Ryu et al., 2010).
In the alimentary canal, TRPV1 occurs in extrinsic sensory neurons,
intrinsic enteric neurons as well as epithelial and endocrine cells. The
major cellular sources of TRPV1 in the rat, guinea-pig and murine
alimentary canal are spinal and vagal primary afferent neurons
(Patterson et al., 2003; Ward et al., 2003; Holzer, 2004; Horie et al.,
2004; Kadowaki et al., 2004; Robinson et al., 2004; Schicho et al.,
2004; Banerjee et al., 2007; Ryu et al., 2010; Zhao et al., 2010). Both
in the DRG and nodose ganglion cells, TRPV1 is restricted to small
and medium-sized somata that are known to give rise to unmyelin-
ated (C-) and thinlymyelinated (Aδ-) ﬁbers (Caterina et al., 1997; Guo
et al., 1999; Michael & Priestley, 1999; Banerjee et al., 2007; Tan et al.,
2008, 2009). There are distinct regional differences in the relative
proportion of sensory neurons that stain positive for TRPV1. Thus,
TRPV1-immunoreactive ﬁbers are considerably more prevalent in
visceral than in somatic afferent neurons (Robinson et al., 2004;
Brierley et al., 2005; Hwang et al., 2005; Christianson et al., 2006a). In
fact, the majority of nodose ganglion neurons projecting to the rodent
stomach and of DRG neurons projecting to the rodent gut express
TRPV1 (Robinson et al., 2004; Schicho et al., 2004; Zhang et al., 2004;
Brierley et al., 2005; Hwang et al., 2005; Christianson et al., 2006a,
2006b; Tan et al., 2008; Zhong et al., 2008), while only 32% of the vagal
afferent neurons supplying the murine jejunum contain TRPV1 (Tan
et al., 2009).
Within the rodent and human alimentary canal, TRPV1-positive
nerve ﬁbers occur in the musculature, enteric nerve plexuses,
arterioles and mucosa (Facer et al., 2001; Yiangou et al., 2001; Chan
et al., 2003; Patterson et al., 2003; Ward et al., 2003; Holzer, 2004;
Horie et al., 2004; Kadowaki et al., 2004; Matthews et al., 2004;
Robinson et al., 2004; Schicho et al., 2004; Zhang et al., 2004;
Faussone-Pellegrini et al., 2005; Bhat & Bielefeldt, 2006; Akbar et al.,
2008; Matsumoto et al., 2009, 2011). In addition, TRPV1 is present in
nerve ﬁbers supplying the taste papillae of the tongue (Caterina et al.,
1997; Tominaga et al., 1998; Ishida et al., 2002; DeSimone & Lyall,
2006).
There are regional and species differences in the chemical coding
of primary afferent neurons expressing TRPV1. Thus, calcitonin gene-
related peptide (CGRP), substance P, somatostatin and other neuro-
peptides are messenger molecules characteristic of capsaicin-sensitive
DRG neurons (Green & Dockray, 1988; Holzer, 1991; Sternini, 1992;
Szallasi & Blumberg, 1999; Hwang et al., 2005; Price & Flores, 2007),
while CGRP is absent from vagal afferent neurons containing TRPV1
(Tan et al., 2009). DRG neurons can be largely differentiated by their
binding of isolectin B4 and their responsiveness to different
neurotrophins (Guo et al., 1999; Michael & Priestley, 1999; Liu et al.,
2004; Hwang et al., 2005; Price & Flores, 2007). In adult rodents, the
isolectin B4-negative cell population responds to nerve growth factor,
while isolectin B4-positive cells respond to the glial cell line-derived
family of neurotrophins. However, there is no clear distinction
between these groups of DRG neurons in their expression of TRPV1
and the neuropeptides substance P, CGRP and somatostatin (Price &
Flores, 2007). In the rat, TRPV1 is found in both populations of DRG
neurons but is more prevalent in isolectin B4-positive cells (Guo et al.,
1999; Michael & Priestley, 1999; Liu et al., 2004; Hwang et al., 2005;
Banerjee et al., 2007; Price & Flores, 2007), whereas in the mouse
TRPV1 is largely absent from isolectin B4-positive DRG cells (Zwicket al., 2002; Woodbury et al., 2004; Price & Flores, 2007). In both rat
and mouse, however, TRPV1 abounds in visceral DRG neurons that
bind little isolectin B4 but are rich in CGRP and substance P (Ward et al.,
2003; Robinson et al., 2004; Schicho et al., 2004; Brierley et al., 2005;
Hwang et al., 2005; Christianson et al., 2006a, 2006b; Tan et al., 2008).
The presence of TRPV1 in the enteric nervous system has been less
extensively studied than that in primary afferent neurons and has
remained a matter of controversy. While some authors have localized
TRPV1 immunoreactivity to somata of the guinea-pig, porcine and
human enteric nervous system (Nozawa et al., 2001; Poonyachoti
et al., 2002; Anavi-Goffer & Coutts, 2003; Chan et al., 2003), other
authors have failed to conﬁrm this location (Patterson et al., 2003;
Ward et al., 2003; Holzer, 2004; Schicho et al., 2004). Importantly, the
chemical coding of TRPV1-positive DRG neurons innervating the
murine gut and of TRPV1-positive nerve ﬁbers in the murine colon
and rectum is distinct from that of enteric neurons (Tan et al., 2008;
Matsumoto et al., 2011). Furthermore, TRPV1 messenger ribonucleic
acid (mRNA) disappears from the rat stomach following extrinsic
denervation (Schicho et al., 2004). Enteric neurons that issue
projections from the rat colon to the spinal cord are likewise
TRPV1-negative (Suckow & Caudle, 2008). The inconsistencies in
the localization of TRPV1 to enteric neurons could in part be explained
by the existence of several splice variants of TRPV1 (Wang et al., 2004;
Faussone-Pellegrini et al., 2005; Szallasi et al., 2007) that may
substantially differ in their immunoreactivity. For instance, two
splicing products of the murine TRPV1 gene have been identiﬁed in
the DRGs and several tissues including the gut. One of them, TRPV1-α,
is equivalent to the rat and human TRPV1, whereas the other one,
TRPV1-β, encodes a dominant negative subunit of the TRPV1 channel
(Wang et al., 2004).
In addition to its prominent location in neurons, TRPV1 has been
localized to non-neural cells of the alimentary canal. Thus, TRPV1-like
immunoreactivity is found in the human submandibular gland where
it occurs in serous acinar and ductal cells, but not in mucous acinar
cells (Ding et al., 2010). Furthermore, TRPV1-like immunoreactivity
has been localized to gastrin and parietal cells of the stomach as well
as to epithelial cells of the esophageal, gastric and small intestinal
mucosa of several species including man (Nozawa et al., 2001; Kato
et al., 2003; Zhang et al., 2004; Faussone-Pellegrini et al., 2005;
Kechagias et al., 2005; Cheng et al., 2009; Ericson et al., 2009; Ma et al.,
2010). With respect to the presence of TRPV1 in these tissues a word
of caution is in place, given that TRPV1 antisera can yield false positive
staining in non-neural tissues, which persists in TRPV1 knockout mice
(Everaerts et al., 2009).
2.2.2. Functional implications of TRPV1 in the digestive system
2.2.2.1. Sensory modalities of TRPV1. TRPV1 is a sensor that is stimulated
by several spices, noxious heat, and a number of endogenous stimuli,
some of which are particularly relevant to the GI tract (Table 1). Among
the spices acting on TRPV1, capsaicin (red pepper), piperine (black
pepper), gingerol and zingerone (ginger), pungent compounds from
onion and garlic, eugenol (clove) and camphor ﬁgure most prominent-
ly. TRPV1 is also activated by allyl isothiocyanate present in mustard,
horseradish and wasabi (Everaerts et al., 2011), resiniferatoxin, a toxin
of tropical Euphorbia plants (Szallasi & Blumberg, 1999), and
“vanillotoxins” present in the venoms of the Trinidad Chevron tarantula
and Earth Tiger tarantula (Cromer & McIntyre, 2008; Bohlen et al.,
2010). A taste variant of TRPV1 is thought to be involved in nonspeciﬁc
salt taste perception (DeSimone & Lyall, 2006). Furthermore, TRPV1
contributes to the aversive bitter aftertaste sensation evoked by high
concentrations of artiﬁcial sweeteners such as saccharin and acesul-
fame-K and to the metallic taste sensation evoked by high concentra-
tions of CuSO4, ZnSO4 and FeSO4 (Riera et al., 2007). The burning
sensation evoked by ethanol in themouth and throat is also most likely
mediated by TRPV1 (Trevisani et al., 2002). The endogenous stimuli
Table 1
Overview of TRP channels with a chemosensory role in the alimentary canal.
TRP channel Sensory modalities in
general
Select chemical agonists References (regarding chemical agonists)
TRPV1 Heat (N42 °C) Spices
Pungent spices Allicin (garlic, onion) Macpherson et al., 2005
Salt taste Allyl isothiocyanate (mustard, horseradish, wasabi) Everaerts et al., 2011
Acidosis Camphora Xu et al., 2005
Alkalosis Cannabidiol (Cannabis sativa) Bisogno et al., 2001
Chemesthesis Capsaicin (red pepper, Capsicum ssp.) Caterina et al., 1997
Chemical pain Citral (lemongrass) Stotz et al., 2008
Distension Eugenol (clove) Bandell et al., 2007
Evodiamine (Evodia rutaecarpa) Pearce et al., 2004
Geraniol (citronella grass, Geranium ssp.) Stotz et al., 2008
Gingerol (ginger) Bandell et al., 2007
Isovelleral (Lactarius vellereus) Szallasi et al., 1996; Ralevic et al., 2003
6-Paradol (Sichuan pepper) Riera et al., 2009
Piperine and other black pepper constituents (dehydropipernonaline,
isochavicine, isopiperine, piperanine, pipernonaline, piperolein A and B,
retrofractamide C)
Andrè et al., 2006; Okumura et al., 2010
Polygodial (Polygonum hydropiper) Szallasi & Blumberg, 1999
6-Shogaol (Sichuan pepper) Riera et al., 2009
Zingerone (ginger) Bandell et al., 2007
Natural toxins
Brevetoxin (ciguatera and shellﬁsh toxin) Cuypers et al., 2007
Gambierol (ciguatera and shellﬁsh toxin) Cuypers et al., 2007
Resiniferatoxin (Euphorbia resinifera) Bandell et al., 2007
Vanillotoxin DkTx (Earth Tiger tarantula venom) Bohlen et al., 2010
Vanillotoxins VaTx1, VaTx2, VaTx3 (Trinidad Chevron tarantula venom) Cromer & McIntyre, 2008
Endogenous and exogenous chemicals
Acesulfame-K Riera et al., 2007
Acid (pHb6) Tominaga et al., 1998
2-Aminoethoxydiphenyl borate Hu et al., 2004
Ammonia (pHN8) Dhaka et al., 2009
Anandamide Zygmunt et al., 1999
Clotrimazole Meseguer et al., 2008
CuSO4 Riera et al., 2007
Ethanol Trevisani et al., 2002
FeSO4 Riera et al., 2007
12-(S)-Hydroperoxy eicosatetraenoic acid Hwang et al., 2000
15-(S)-Hydroperoxy eicosatetraenoic acid Hwang et al., 2000
Leukotriene B4 Hwang et al., 2000
N-arachidonoyl-dopamine Huang et al., 2002
Nitric oxide Miyamoto et al., 2009
Nitro-oleic acid (antiinﬂammatory nitric oxide derivative) Sculptoreanu et al., 2010
N-oleoyldopamine Chu et al., 2003
Oleoylethanolamide Wang et al., 2005
Polyamines (putrescine, spermidine, spermine) Ahern et al., 2006
Propofol Fischer et al., 2010
Saccharin Riera et al., 2007
ZnSO4 Riera et al., 2007
TRPV2 Heat (N52 °C)
Hypotonicity
Natural compounds
Cannabidiol (Cannabis sativa) Qin et al., 2008
Δ9-Tetrahydrocannabinol (Cannabis sativa) Qin et al., 2008
Synthetic chemicals
2-Aminoethoxydiphenyl borate Hu et al., 2004; Stotz et al., 2008
Probenecid Bang et al., 2007b
TRPV3 Warmth (22–40 °C) Spices
Spices (+)-Borneol (Borneo camphor) Vogt-Eisele et al., 2007
Chemesthesis Camphora Macpherson et al., 2006; Vogt-Eisele et al., 2007
Chemical pain Carvacrol (oregano) Xu et al., 2006; Vogt-Eisele et al., 2007
Carveol (spearmint oil) Vogt-Eisele et al., 2007
Citral (lemongrass) Stotz et al., 2008
Dihydrocarveol (caraway and other plants) Vogt-Eisele et al., 2007
Eugenol (clove) Xu et al., 2006
Geraniol (citronella grass, Geranium ssp.) Stotz et al., 2008
Menthol (mint) Macpherson et al., 2006
Thymol (thyme) Xu et al., 2006; Vogt-Eisele et al., 2007
Vanillin (vanilla) Xu et al., 2006
Synthetic chemicals
2-Aminoethoxydiphenyl borate Hu et al., 2004; Stotz et al., 2008
Ethyl vanillin Xu et al., 2006
6-Tert-butyl-m-cresol Vogt-Eisele et al., 2007
TRPV4 Warmth (N25–34 °C) Endogenous and exogenous chemicals
Acidosis Acid (pHb6) Suzuki et al., 2003
Hypotonicity Bisandrographolide A (Andrographis paniculata) Smith et al., 2006
Distension Citrate Suzuki et al., 2003
5′,6′-Epoxy eicosatrienoic acid Watanabe et al., 2003
(continued on next page)
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Table 1 (continued)
TRP channel Sensory modalities in
general
Select chemical agonists References (regarding chemical agonists)
4α-Phorbol 12,13-didecanoate Watanabe et al., 2002
TRPM5 Sweet, umami and bitter
taste
Sweet, umami and bitter tastants Zhang et al., 2003; Damak et al., 2006; Kaske et al., 2007
TRPM8 Cold (b25 °C) Spices
Spices L-Carvone (Mentha spicata) Bandell et al., 2007
Cold pain Citral (lemongrass) Stotz et al., 2008
Chemesthesis Eucalyptol (Eucalyptus polybractea) Behrendt et al., 2004
Chemical pain Eugenol (clove) Behrendt et al., 2004
Geraniol (citronella grass, Geranium ssp.) Behrendt et al., 2004; Stotz et al., 2008
Isopulegol (Mentha pulegium) Bandell et al., 2007
Linalool (Onagraceae ssp.) Behrendt et al., 2004
Menthol (mint)b McKemy et al., 2002; Peier et al., 2002
Synthetic chemical
Icilin McKemy et al., 2002
TRPP2 Sour taste Acid Chandrashekar et al., 2006; Huang et al., 2006;
Ishimaru et al., 2006
TRPA1 Cold (b17 °C) Spices
Pungent spices 1′-Acetoxychavicol acetate (galangal) Narukawa et al., 2010
Alkalosis Allicin (garlic, onion) Bautista et al., 2005; Macpherson et al., 2005
Chemesthesis Allyl isothiocyanate (mustard, horseradish, wasabi) Story et al., 2003; Jordt et al., 2004
Chemical pain Benzyl isothiocyanate (yellow mustard) Jordt et al., 2004
Distension Carvacrol (oregano) Xu et al., 2006; Lee et al., 2008
Cinnamaldehyde (cinnamon)c Bandell et al., 2004
Citral (lemongrass) Stotz et al., 2008
Diallyl disulﬁde (garlic, onion) Bautista et al., 2005; Macpherson et al., 2005
Eugenol (clove) Bandell et al., 2004
Geraniol (citronella grass, Geranium ssp.) Stotz et al., 2008
Gingerol (ginger) Bandell et al., 2004
Isopropyl isothiocyanate (Nasturtium seeds) Jordt et al., 2004
Linalool (Sichuan pepper) Riera et al., 2009
Methyl isothiocyanate (Capparis spinosa) Jordt et al., 2004
Methyl salicylate (wintergreen) Bandell et al., 2004
6-Paradol (Sichuan pepper) Riera et al., 2009
Phenylethyl isothiocyanate (Brussels sprouts) Jordt et al., 2004
Piperine and other black pepper constituents (isochavicine,
isopiperine, piperanine, piperolein A and B)
Okumura et al., 2010
6-Shogaol (Sichuan pepper) Riera et al., 2009
Thymol (thyme) Lee et al., 2008
Natural toxin
GsMTx-4 (tarantula toxin) Hill & Schaefer, 2007
Endogenous and exogenous chemicals
Acetaldehyde Bang et al., 2007a, 2007b
Acrolein Bautista et al., 2006
2-Aminoethyl methanethiosulfonate Macpherson et al., 2007a
Ammonia Fujita et al., 2008
Bradykinin Bandell et al., 2004; Bautista et al., 2006
Carbon dioxide Wang et al., 2010
Croton aldehyde (cigarette smoke) Andrè et al., 2008
Cyclopentenone prostaglandin metabolites Andersson et al., 2008; Materazzi et al., 2008; Maher et
al., 2008
Farnesyl thiosalicylic acid Maher et al., 2008
Formaldehyde Macpherson, Xiao, et al., 2007; McNamara et al., 2007
H2S Streng et al., 2008
H2O2 (oxidative insult) Andersson et al., 2008; Bessac et al., 2008; Sawada et al.,
2008
4-Hydroxy-2-nonenal (oxidative insult) Macpherson et al., 2007b; Trevisani et al., 2007
Hypochlorite (oxidative insult) Bessac et al., 2008
Icilin Bandell et al., 2007
Iodoacetamide Macpherson et al., 2007a
Methyl isocyanate Bessac et al., 2009
Methyl p-hydroxybenzoate Fujita et al., 2007
Naphthalene metabolites Lanosa et al., 2010
Nicotine Talavera et al., 2009
Nitric oxide Miyamoto et al., 2009
Nitro-oleic acid (antiinﬂammatory nitric oxide derivative) Sculptoreanu et al., 2010
4-Oxo-nonenal (oxidative insult) Andersson et al., 2008; Taylor-Clark et al., 2008
Ozone Taylor-Clark and Undem, 2010
Tear gas (morphanthridine analogs) Bessac et al., 2009; Gijsen et al., 2010
Δ9-Tetrahydrocannabinol Jordt et al., 2004
Toluene diisocyanate Taylor-Clark et al., 2009
Drugs
N-Acetyl-p-benzo-quinoneimine (metabolite of acetaminophen) Nassini et al., 2011
Clioquinol Andersson et al., 2009
Chlordantoin Maher et al., 2008
Clotrimazoled Meseguer et al., 2008
Diclofenac Hu et al., 2010
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Table 1 (continued)
TRP channel Sensory modalities in
general
Select chemical agonists References (regarding chemical agonists)
1,4-Dihydropyridines (nicardipine, nifedipine, nimodipine) Fajardo et al., 2008
Disulﬁram Maher et al., 2008
Flufenamic acide Hu et al., 2010
Flurbiprofen Hu et al., 2010
Indomethacin Hu et al., 2010
Isoﬂurane Eilers et al., 2010
Ketoprofen Hu et al., 2010
Mefenamic acid Hu et al., 2010
Niﬂumic acid Hu et al., 2010
Propofol Lee et al., 2008; Fischer et al., 2010
a Camphor activates TRPV1 and TRPV3 but inhibits TRPA1 (Xu et al., 2005).
b Menthol activates TRPM8 but inhibits TRPA1 (Macpherson et al., 2006).
c Cinnamaldehyde activates TRPA1 but inhibits TRPM8 (Macpherson et al., 2006).
d Clotrimazole activates both TRPA1 and TRPV1 but blocks TRPM8 (Meseguer et al., 2008).
e Flufenamic acid activates TRPA1 but inhibits TRPV1, TRPV3 and TRPM8 (Hu et al., 2010). For further details see Geppetti and Trevisani (2004), Vriens et al. (2008, 2009), Baraldi
et al. (2010), and Boesmans et al. (2011).
TRPA1
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anandamide and other arachidonic acid-derivedmetabolites such as N-
arachidonoyl-dopamine, N-oleoyldopamine, oleoylethanolamide, 12-
(S)-hydroperoxy eicosatetraenoic acid, 15-(S)-hydroperoxy eicosate-
traenoic acid and leukotriene B4 (Tominaga et al., 1998; Caterina &
Julius, 2001; Holzer, 2007; Szallasi et al., 2007; Dhaka et al., 2009).
2.2.2.2. Role of TRPV1 in abdominal pain and hypersensitivity. Several
lines of evidence indicate that TRPV1 is involved in pain and
hyperalgesia throughout the alimentary canal. In addition, TRPV1-
expressing vagal afferents in the esophagus may contribute to the
cough evoked by gastro-esophageal reﬂux of gastric contents
(Kollarik & Brozmanova, 2009). In keeping with its nociceptive role,
activation of TRPV1 on primary afferent neurons innervating the gut
elicits pain in humans and pain-related behavior in rodents (Table 2).
Intraesophageal instillation of capsaicin in human volunteers evokes
symptoms of heartburn, while the sensitivity to balloon distension or
acid exposure remains unchanged (Kindt et al., 2009; Chen et al.,
2010). Intragastric administration of capsaicin in humans increases
the sensitivity to proximal gastric distension (Lee et al., 2004), and
ingestion of capsaicin capsules induces gastric sensations of pressure,
heartburn and warmth (Hammer & Vogelsang, 2007). Infusion of
capsaicin into the proximal small intestine of human volunteers
likewise evokes sensations of pain, cramps, pressure, warmth and
nausea (Schmidt et al., 2004; Hammer & Vogelsang, 2007). The
capsaicin-induced sensations are most intense in the duodenum and
appear to decrease along the intestine (Hammer & Vogelsang, 2007),
although local capsaicin instillation in ileostomy and colostomy
patients is also painful (Drewes et al., 2003; Arendt-Nielsen et al.,
2008). Ingestion of capsaicin for 7 days leads to a decrease in jejunal
mechanosensation and to an increase in the jejunal sensitivity to
capsaicin (Hammer, 2006a), and oral chili intake for 3 days has been
reported to increase rectal sensitivity to urgency (Gonlachanvit et al.,
2007). In contrast, ingestion of capsaicin (0.25 mg) capsules three
times per day for 4 weeks leads to desensitization of the duodenum to
both acute capsaicin administration and balloon distension (Führer &
Hammer, 2009).
TRPV1 can be sensitized by many proalgesic factors (Caterina &
Julius, 2001; Geppetti & Trevisani, 2004; Szallasi et al., 2007; Holzer,
2008b), and there is increasing evidence that GI inﬂammation causes
chemical and mechanical hyperalgesia at least in part by upregulation
and sensitization of TRPV1 (Table 2). Neurotrophins, various
inﬂammatory mediators as well as endocrine factors of the GI mucosa
are thought to be involved in this process. Thus, the ability of 5-
hydroxytryptamine (5-HT) to sensitize GI afferent neurons to heat,
acid and capsaicin is absent in TRPV1 knockout mice (Sugiura et al.,2004). The effect of 5-HT to sensitize colonic DRG neurons is mediated
by metabotropic 5-HT2 and 5-HT4 receptors which appear to enhance
TRPV1 activity by downstream phosphorylation pathways (Sugiura
et al., 2004). Vice versa, depletion of 5-HT from the colon by pre-
treatment of rats with p-chlorophenylalanine reduces the excitability
of DRG neurons by capsaicin and elevates the threshold of distension-
induced pain behavior (Qin et al., 2010). Referred hyperalgesia
associated with caerulein-induced pancreatitis in mice depends on
both protease-activated receptor-2 (PAR-2) and TRPV1, TRPV1 being
a downstream transducer of the pronociceptive action of PAR-2
stimulation (Fukushima et al., 2010; Nishimura et al., 2010).
TRPV1 is upregulated not only in inﬂammation, but also in the
absence of overt inﬂammation (Table 2) as is typical of functional GI
disorders (Holzer, 2008a). This is true for patients with irritable bowel
syndrome in which the increased density of TRPV1 in the rectosigmoid
colon correlates with pain severity (Akbar et al., 2008). A similar
correlation between pain intensity and number of mucosal TRPV1-
positive nerve ﬁbers is found in patients with quiescent inﬂammatory
bowel disease who continue to complain of abdominal pain (Akbar
et al., 2010). Non-erosive reﬂux disease (Bhat & Bielefeldt, 2006;
Guarino et al., 2010), idiopathic rectal hypersensitivity and fecal
urgency (Chan et al., 2003) are other instances of TRPV1 upregulation
in the absence of appreciable inﬂammation. In addition, patients with
functional dyspepsia (Hammer et al., 2008) and diarrhea-predominant
irritable bowel syndrome (Gonlachanvit et al., 2009) exhibit hyper-
sensitivity to the painful sensations evoked by capsaicin-containing
capsules. Experimental ﬁndings have likewise shown that TRPV1 has a
bearing on post-inﬂammatory colonic hyperalgesia in rodents, given
that upregulation of TRPV1 expression and function persists long after
the initial inﬂammatory insult has subsided (Eijkelkamp et al., 2007;
Jones et al., 2007; Winston et al., 2007; Holzer, 2008b).
Although the participation of TRPV1 in chemical nociception ﬁgures
most prominently, there is evidence that TRPV1 also contributes to
mechanical hyperalgesia in the inﬂamed gut (Table 2). As shown for
pelvic afferents innervating the murine colon, TRPV1 is preferentially
expressed by mechanoreceptors that respond to distension with a low
frequency of ﬁring, the distension responses of these ﬁbers being
sensitized by capsaicin or acidosis (Malin et al., 2009). Pelvic afferents
innervating the smooth muscle and myenteric plexus of the murine
rectum are likewise sensitive to low-threshold distension and capsaicin
(Spencer et al., 2008). Accordingly, capsaicin enhances the visceromo-
tor response to colorectal distension (an indirect measure of abdominal
pain), this effect being inhibited by the TRPV1 blocker SB-705,498 (van
den Wijngaard et al., 2009a). Similarly, the hypersensitivity to
colorectal distension, which is seen after acute stress exposure of
adult rats that have been subjected to maternal separation as neonates,
Fig. 1. Diagram portraying 3 different molecular roles of TRP channels in the digestive system: (1) TRP channels as molecular sensors (detectors or primary transducers) of chemical
and physical stimuli, (2) TRP channels as secondary transducers (downstream transducers or effectors) of cell activation induced by G protein-coupled receptors or ion channel
receptors, and (3) TRP channels as Ca2+ or Mg2+ transport channels.
148 P. Holzer / Pharmacology & Therapeutics 131 (2011) 142–170is reversed by TRPV1 blockade (van den Wijngaard et al., 2009b). This
ﬁnding is consistent with a report that chronic exposure of adult rats to
water avoidance stress for 10 days causes a signiﬁcant upregulation of
TRPV1 (and TRPA1) in DRG neurons supplying the colon, along with an
increase in the abdominal withdrawal reﬂex to colorectal distension
(Yu et al., 2010). Furthermore, TRPV1 blockade prevents the develop-
ment of mechanical hyperalgesia that is evoked by repetitive colorectalTra
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Fig. 3. Overview of the associations of TRP channels with diseases and disorders of the digestive system.
149P. Holzer / Pharmacology & Therapeutics 131 (2011) 142–170role of TRPV1 has not yet been substantiated. The implication of TRPV1
in inﬂammatory hypersensitivity is likewise that of a secondary
transducer, TRPV1 channel activity being enhanced by multiple
mechanisms triggered by receptors for inﬂammatory mediators and
neurotrophins.
2.2.2.3. Role of TRPV1 in emesis. A prominent role of vagal afferent
neurons supplying the upper GI tract is to cause nausea and vomiting
if the ingested food is deemed potentially or actually toxic. In view ofInflamm
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Table 2
Select implications of TRPV1 in the physiology and pathophysiology of the digestive tract.
Tissue Physiological or pathophysiological process Type of evidence References
Submandibular salivary gland Acinar cell activation and salivary secretion in response
to TRPV1 stimulation in humans
Induction by TRPV1 agonism Ding et al., 2010; Zhang et al., 2010
Esophagus, stomach and \intestine Stimulation of vagal and spinal afferent nerve ﬁbers by
capsaicin, acid and/or distension in rodents
Induction by TRPV1 agonism and prevention by TRPV1
knockout and/or antagonism
Maubach & Grundy, 1999; Su et al., 1999; Blackshaw et al.,
2000; Rong et al., 2004; Sugiura et al., 2007; Bielefeldt &
Davis, 2008; Peles et al., 2009
Esophagus, stomach and intestine Hyperemia, bicarbonate secretion and protection of the
mucosa from chemical injury (acid, ethanol, nosteroidal
antiinﬂammatory drugs) in rats and humans
Induction by TRPV1 agonism Hamid et al., 1981; Szolcsányi & Barthó, 1981; Holzer & Lippe,
1988; Holzer et al., 1989; Yeoh et al., 1995; Holzer, 1998, 2002;
Aihara et al., 2005; Akiba et al., 2006a, 2008; Massa et al., 2006
Esophagus, stomach and intestine Patients with erosive gastro-esophageal reﬂux disease,
non-erosive reﬂux disease, irritable bowel syndrome,
inﬂammatory bowel disease, idiopathic rectal
hypersensitivity and fecal urgency, and Hirschsprung's
disease
Upregulation of TRPV1 in the mucosa, with a correlation
to pain sensitivity in irritable bowel syndrome and in
inﬂammatory bowel disease with irritable bowel
syndrome-like symptoms
Facer et al., 2001; Yiangou et al., 2001; Chan et al., 2003;
Matthews et al., 2004; Bhat & Bielefeldt, 2006; Akbar et al.,
2008, 2010; Guarino et al., 2010; Shieh et al., 2010
Esophagus, stomach, intestine and
pancreas
Acid-induced oesophagitis, gastric acid-evoked injury
of the stomach, trinitrobenzene sulfonic acid-induced
pancreatitis and colitis in rodents
Upregulation of TRPV1 in vagal and spinal afferent neurons Schicho et al., 2004; Banerjee et al., 2007; Miranda et al.,
2007; Xu et al., 2007
Esophagus, stomach and small
intestine
Abdominal pain in human volunteers Induction by intraluminal capsaicin Schmidt et al., 2004; Hammer, 2006a, 2006b; Hammer &
Vogelsang, 2007; Hammer et al., 2008; Führer & Hammer,
2009; Kindt et al., 2009; Chen et al., 2010; van Boxel et al.,
2010
Stomach Behavioral pain response to intragastric acid challenge
in rats
Prevention by TRPV1 antagonism Lamb et al., 2003
Stomach and upper small intestine Functional dyspepsia Hypersensitivity to the algesic effect of
capsaicin
Hammer et al., 2008
Stomach and upper small intestine Functional dyspepsia Beneﬁcial effect of 5 week ingestion of
capsaicin capsules
Bortolotti et al., 2002
Duodenum Pain sensitivity to capsaicin exposure and balloon
distension in humans
Beneﬁcial effect of 4 week ingestion of
capsaicin capsules
Führer & Hammer, 2009
Jejunum Cardiovascular pain response to noxious distension in rats Attenuation by TRPV1 ablationa Lembeck & Skoﬁtsch, 1982
Ileum Ileitis induced by Clostridium difﬁcile toxin A in rodents Attenuation by TRPV1 antagonism McVey & Vigna, 2001
Ileum and colon Abdominal pain and viscerosomatic reﬂexes in humans Intraluminal administration of capsaicin to ileostomy
and colostomy patients
Drewes et al., 2003; Arendt-Nielsen et al., 2008
Colon Abdominal pain in rodents Induction by intraluminal capsaicin Laird et al., 2001; Mansikka et al., 2004; Christoph et al., 2006
Colon Hypersensitivity to balloon distension in humans Ingestion of capsaicin capsules Gonlachanvit et al., 2007
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Table 2 (continued)
Tissue Physiological or pathophysiological process Type of evidence References
Colon Abdominal pain and burning in patients with
diarrhea-predominant irritable bowel syndrome
Hypersensitivity to ingestion of chili capsules Gonlachanvit et al., 2009
Colon Hyperalgesia caused by repetitive colorectal distension
in rats
Prevention by TRPV1 antagonism Ravnefjord et al., 2009
Colon Sensitization of murine afferent nerve ﬁbers to heat,
acid and capsaicin by 5-hydroxytryptamine
Attenuation by TRPV1 knockout Sugiura et al., 2004
Colon Hyperalgesia to intraluminal acid and colorectal distension
in rodents with acute experimental colitis
Attenuation by TRPV1 ablation, knockout and antagonism Plourde et al., 1997; Delafoy et al., 2003; Jones et al., 2005,
2007; Miranda et al., 2007
Colon Acute stress-evoked hyperalgesia to colorectal distension
in rats subjected to maternal separation as neonates
Prevention by TRPV1 antagonism van den Wijngaard et al., 2009b
Colon Water avoidance stress-induced upregulation of TRPV1
in rat DRG neurons and hypersensitivity to colorectal
distension
Prevention by TRPV1 antagonism Hong et al., 2009
Colon Post-inﬂammatory chemical and mechanical hyperalgesia
in rodents
Attenuation by TRPV1 knockout and antagonism Eijkelkamp et al., 2007; Jones et al., 2007; Winston et al.,
2007; Wiskur et al., 2010
Colon Colitis induced by dextran sulfate or trinitrobenzene
sulfonic acid in rodents
Attenuation by TRPV1 knockout and antagonism Kihara et al., 2003; Kimball et al., 2004; Miranda et al., 2007;
Szitter et al., 2010
Colon Colitis induced by trinitrobenzene sulfonic acid in rats Upregulation of TRPV1 in and sensitization of colon-speciﬁc
pelvic DRG neurons
De Schepper et al., 2008
Colon Colitis-induced inhibition of gastric emptying in rats Prevention by TRPV1 antagonism De Schepper et al., 2008
Colon Colitis induced by T-cell transfer in mice Prevention by TRPV1 ablation Gad et al., 2009
Colon Secretory responses induced by distension or H2S in
guinea-pig and human preparations
Attenuation by TRPV1 ablation and antagonism Weber et al., 2001; Krueger et al., 2010
Anus Intractable idiopathic pruritus ani Attenuation by TRPV1 ablation Lysy et al., 2003
Pancreas Chronic pancreatitis induced by trinitrobenzene sulfonic
acid in rats
Upregulation and sensitization of TRPV1 in pancreas-speciﬁc
DRG neurons
Xu et al., 2007
Pancreas Pancreatitis induced by caerulein in mice Attenuation by TRPV1 antagonism Nathan et al., 2001
Pancreas Acid-evoked injury in a rat model of post-endoscopic
cholangiopancreatography pancreatitis
Attenuation by TRPV1 ablation Noble et al., 2008
Pancreas Islet inﬂammation in non-obese diabetic mice (genetic
model of type I diabetes)
Prevention by TRPV1 ablation Razavi et al., 2006; Suri & Szallasi, 2008
Pancreas Pain behavior, referred allodynia/hyperalgesia and spinal
c-Fos expression associated with experimental pancreatitis
in rodents
Attenuation by TRPV1 antagonism Wick et al., 2006; Xu et al., 2007; Nishimura et al., 2010
Peritoneal cavity Behavioral pain response to intraperitoneal injection of
acetic acid or oleoylethanolamide in rodents
Attenuation by TRPV1 antagonism Urban et al., 2000; Ikeda et al., 2001; Rigoni et al., 2003;
Wang et al., 2005; Tang et al., 2007
a TRPV1 ablation refers to pretreatment with capsaicin or resiniferatoxin to defunctionalize afferent neurons.
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152 P. Holzer / Pharmacology & Therapeutics 131 (2011) 142–170stimulation of the medial solitary nucleus in the brainstem, radiation,
systemic administration of cisplatin, loperamide or apomorphine or
intragastric administration of CuSO4 is depressed by capsaicin and
resiniferatoxin (Andrews & Bhandari, 1993; Shiroshita et al., 1997;
Andrews et al., 2000; Rudd &Wai, 2001; Yamakuni et al., 2002). Since
the mechanism behind the dual proemetic and antiemetic action of
TRPV1 agonists is not understood, the existence of a novel vanilloid
receptor has been envisaged (Cheng et al., 2005). Non-pungent agonists
at TRPV1 such as arvanil, olvanil, anandamide and N-arachidonoyl-
dopamine fail to evoke emesis in the ferret but are able to blunt vom-
iting evoked by morphine-6-glucuronide, apomorphine, cisplatin and
CuSO4 (Sharkey et al., 2007; Chu et al., 2010).
2.2.2.4. Thermoregulation by abdominal TRPV1. TRPV1 is a heat sensor
(Caterina et al., 1997; Tominaga et al., 1998), which explains why the
sensation caused by capsaicin is described as “hot” and “burning”.
Although capsaicin and related TRPV1 agonists evoke a thermoreg-
ulatory response (Szallasi & Blumberg, 1999; Masamoto et al., 2009),
TRPV1 knockout mice have a normal body temperature and do not
seem to have a deﬁcit in heat sensing (Szelényi et al., 2004;Woodbury
et al., 2004; Iida et al., 2005), except that heat hyperalgesia in
response to inﬂammation (Caterina et al., 2000; Davis et al., 2000) or
heat injury (Bölcskei et al., 2005) and fever in response to the bacterial
pyrogen lipopolysaccharide (Iida et al., 2005) are attenuated. The
maintenance of basal thermoregulation in TRPV1 knockout mice is
probably due to developmental compensations, given that many
TRPV1 blockers cause substantial hyperthermia in mice, rats, dogs,
monkeys and humans (Gavva et al., 2007, 2008; Steiner et al., 2007;
Holzer, 2008b; Garami et al., 2010). It need be inferred, therefore, that
TRPV1 is tonically active to control core body temperature (Gavva et
al., 2007; Montell & Caterina, 2007), lowering body temperature
through suppression of autonomic cold-defense effectors (Gavva,
2008; Romanovsky et al., 2009).
The hyperthermic action of TRPV1 blockers involves cutaneous
vasoconstriction and shivering-related thermogenesis, but not
warmth-seeking behavior, and is inhibited by the antipyretic drug
acetaminophen (Steiner et al., 2007; Gavva et al., 2008). Because the
magnitude of the hyperthermic effect of the TRPV1 blocker AMG0347
is independent of the baseline temperature, it has been concluded
that the rise of body temperature results from blockade of tonic TRPV1
activation by non-thermal factors (Steiner et al., 2007). Further
analysis suggests that the hyperthermic response to TRPV1 antago-
nists depends on blockade of the proton mode of TRPV1 activation,
either alone or together with the capsaicin mode of TRPV1 activation
(Romanovsky et al., 2009; Garami et al., 2010). However, this issue
has not yet been settled because some TRPV1 antagonists that do not
block the proton mode of TRPV1 activation can elicit hyperthermia
(Gavva et al., 2007) and other TRPV1 blockers that do not cause
hyperthermia affect the proton mode of TRPV1 stimulation (Lehto et
al., 2008; Garami et al., 2010; Voight & Kort, 2010). It thus awaits to be
conﬁrmed that hyperthermia is in fact driven by a low tissue pH,
either alone or together with endovanilloid agonists (Garami et al.,
2010) and that the TRPV1-mediated thermoregulatory action takes
place in the abdominal cavity (Steiner et al., 2007) in which the
stomach and colon have an acidic environment (Holzer, 2007). The
increase in metabolic rate and thermogenesis evoked by intrajejunal
administration of non-pungent capsaicin analogs (capsinoids) to mice
also seems to be mediated by TRPV1 within the GI tract (Kawabata et
al., 2009).
2.2.2.5. Control of digestive functions by TRPV1
2.2.2.5.1. Vasodilatation, tissue protection and inﬂammation. When
TRPV1-expressing sensory nerve ﬁbers are activated, they release
peptide transmitters from their peripheral endings and in this way
modify GI vascular, immune and smooth muscle functions (Holzer,
1998; Barthó et al., 2004, 2008; Holzer, 2004; Mózsik et al., 2007).Following tissue irritation or injury, some of these reactions (e.g.,
vasodilatation and plasma protein extravasation) contribute to the
process of neurogenic inﬂammation. The TRPV1 agonist capsaicin and
mustard oil (a TRPA1 and TRPV1 agonist) have been instrumental in
discovering and analyzing this phenomenon (Holzer, 1988). The
messengers involved in the efferent-like mode of operation include
CGRP, somatostatin and the tachykinins substance P and neurokinin A
(Maggi, 1995; Holzer & Maggi, 1998; Pintér et al., 2006).
Administration of capsaicin to the esophageal, gastric and intestinal
mucosa increasesmucosal blood ﬂow, a responsewhich is mimicked by
exposure to excess acid (Holzer, 1998, 2004). The acid- and carbon
dioxide-evoked hyperemia in the esophageal and duodenal mucosa is
inhibited by the TRPV1 antagonist capsazepine, which indicates that
acid activates TRPV1 on sensory nerve ﬁbers (Akiba et al., 2006a, 2008).
Through this mechanism, which also includes increases in bicarbonate
and mucus secretion, TRPV1-positive sensory nerve ﬁbers are able to
protect the esophageal, gastric and intestinal mucosa from a variety of
injurious insults (Holzer, 1998). Paradoxically, knockout of TRPV1 has
been reported to ameliorate acid-induced injury in the esophagus and
stomach (Akiba et al., 2006b; Fujino et al., 2006). Analysis of this
observation in the stomach suggests that disruption of the TRPV1 gene
causes a compensatory upregulation of several protective mechanisms
in the gastric mucosa (Akiba et al., 2006b). These counterregulatory
mechanisms may also explain why acid-induced release of CGRP from
themurine stomach remains unchanged in TRPV1 knockoutmice (Auer
et al., 2010).
Apart from protecting the GI mucosa (Holzer, 1998; Massa et al.,
2006; Martelli et al., 2007), TRPV1 activation has been found to
exacerbate inﬂammation and injury in certain models of ileitis, colitis
and pancreatitis (Table 2). In addition, capsaicin- as well as acid-
evoked stimulation of epithelial TRPV1 in the feline and human
esophagus has the potential to give rise to esophagitis (Cheng et al.,
2009; Ma et al., 2010). In the murine gastric mucosa, ethanol-induced
injury appears to involve TRPV1-mediated release of neuronal
substance P and subsequent formation of reactive oxygen species
(Gazzieri et al., 2007). Experimental colitis in the mouse is attenuated
by TRPV1 antagonism or knockout (Table 2). Emerging evidence
indicates that TRPV1 contributes to pancreatic islet inﬂammation
associated with type I diabetes and, in addition, plays a role in insulin-
dependent glucose regulation, type II diabetes, adipogenesis and
obesity (Razavi et al., 2006; Gram et al., 2007; Zhang L.L. et al., 2007;
Suri & Szallasi, 2008). The observation that stimulation of TRPV1,
under some conditions, reduces and, under other conditions,
exaggerates tissue inﬂammation and injury may reﬂect stimulus-
and tissue-dependent differences in the process of neurogenic
inﬂammation. In particular, the peptide mediators of TRPV1-positive
afferent neurons cover a wide spectrum of actions: Tachykinins
facilitate inﬂammation, while CGRP promotes vasodilatation but not
necessarily inﬂammation, and somatostatin is capable of inhibiting
inﬂammatory processes (Pintér et al., 2006).
2.2.2.5.2. Motor activity and secretory processes. The messengers
released from capsaicin-sensitive afferent nerve ﬁbers in the gut act
on enteric nervous system, GI smooth muscle and epithelium to
modify motility and secretion (Weber et al., 2001; Holzer, 1998, 2002;
Benkó et al., 2005; Geber et al., 2006; Schicho et al., 2006; Sibaev et al.,
2006; Boudaka et al., 2007; Barthó et al., 2008; de Man et al., 2008;
Matsumoto et al., 2011). Tachykinins and adenosine triphosphate
stimulate motor activity, while CGRP, vasoactive intestinal polypep-
tide and nitric oxide account for motor inhibition caused by TRPV1
activation (Benkó et al., 2005; Barthó et al., 2008; de Man et al., 2008;
Matsumoto et al., 2009). Local motor effects mediated by TRPV1 may
become operative when the GI tract is disturbed by endogenous or
exogenous irritants. For instance, TRPV1 and substance P are involved
in the acid-evoked contraction of opossum esophageal longitudinal
muscle (Paterson et al., 2007). The circular muscle of the isolated
human gut is relaxed by capsaicin, and this effect appears to be
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polypeptide (Barthó et al., 2008). Despite thesemotor effects of TRPV1
stimulation in vitro, the motor activity of the small and large intestine
of experimental animals is maintained at a physiological level
following functional ablation of capsaicin-sensitive afferent neurons
(Barthó et al., 2008). Likewise, no obvious changes in GI motor
function have thus far been reported to occur in mice deﬁcient in
TRPV1.
Ingestion of capsaicin by humans increases amplitude and velocity
of esophageal pressure waves and facilitates secondary peristalsis due
to air injection, decreases proximal gastric tone, inhibits phasic
contractions of the proximal stomach and inhibits gastric emptying,
but does not signiﬁcantly alter orocecal transit time (Gonzalez et al.,
1998; Lee et al., 2004; Chen et al., 2010). The capsaicin-induced
improvement of esophageal motility has been observed in healthy
volunteers as well as in patients with gastro-esophageal reﬂux disease
(Gonzalez et al., 1998; Grossi et al., 2006; Chen et al., 2010). The
relevance of TRPV1 to GI motor control may be most pronounced
under pathopysiological conditions when stimulation of TRPV1 on
sensory nerve ﬁbers causes local messenger release and activation of
sympathetic reﬂexes. In this way, laparotomy or peritoneal irritation
slows GI transit andmay even cause ileus (Holzer et al., 1986; Barquist
et al., 1996; Zittel et al., 2001). This contention is also borne out by the
observation that the gastroparesis associated with experimental
colitis is relieved by TRPV1 blockers (De Schepper et al., 2008).
Secretory functions in the alimentary canal are subject to
regulation by TRPV1 expressed in neurons as well as epithelial cells.
In the human submandibular gland, TRPV1 has been found to activate
acinar cells, to stimulate the trafﬁcking of aquaporin-5 to the cell
membrane and to cause salivary secretion (Ding et al., 2010; Zhang et
al., 2010). Acid- or capsaicin-evoked stimulation of epithelial TRPV1 in
the feline and human esophagus induces the formation of platelet-
activating factor (Cheng et al., 2009; Ma et al., 2010). Exposure of
human isolated antral glands to capsaicin causes release of gastrin and
somatostatin, an effect that is thought to be mediated by TRPV1
expressed by gastrin cells, because it is blunted by a chili-rich diet
ingested for 3 weeks (Ericson et al., 2009). Distension of the guinea-
pig colon (Weber et al., 2001) or exposure of the guinea-pig and
human colon to H2S (Schicho et al., 2006; Krueger et al., 2010) in vitro
evokes a prosecretory effect which depends on activation of TRPV1-
expressing sensory nerve ﬁbers, release of substance P and stimula-
tion of cholinergic secretomotor neurons.
2.2.3. Association of TRPV1 with gastrointestinal disease
Upregulation of TRPV1 tissue levels has been observed in a number
of inﬂammatory and functional GI disorders (Table 2). Thus, both
erosive and non-erosive reﬂux diseases are associated with increased
levels of TRPV1 in the esophageal mucosa (Matthews et al., 2004; Bhat
& Bielefeldt, 2006; Guarino et al., 2010; Shieh et al., 2010). The
upregulation of TRPV1 in the mucosa of patients with erosive
esophagitis is associated with elevated expression of nerve growth
factor and glial cell line-derived neurotrophic factor (Shieh et al.,
2010). Idiopathic rectal hypersensitivity and fecal urgency (Chan et
al., 2003) and Hirschsprung's disease (Facer et al., 2001) are instances
of TRPV1 upregulation in the absence of inﬂammation. Patients with
uninvestigated dyspepsia have been found hypersensitive to intraje-
junal capsaicin infusion (Hammer, 2006b), and a proportion of
patients with functional dyspepsia are more responsive to ingestion
of capsaicin capsules than healthy controls (Hammer et al., 2008). A
role of TRPV1 in upper GI pain is also suggested by the antinociceptive
effect which prolonged treatment with capsaicin-containing capsules
has in healthy volunteers and patients with functional dyspepsia
(Bortolotti et al., 2002; Führer & Hammer, 2009). Furthermore, the
homozygous G315C polymorphism of the TRPV1 gene has been found
to be inversely related to symptom severity in functional dyspepsia
patients (Tahara et al., 2010).Patients suffering from diarrhea-predominant irritable bowel
syndrome exhibit hypersensitivity to the painful and burning
sensations which chili-containing capsules and food elicit in the GI
tract (Gonlachanvit et al., 2009). The TRPV1-positive innervation of
the mucosa in the rectosigmoid colon is increased in patients with
inﬂammatory bowel disease, in patients with irritable bowel
syndrome as well as in patients with quiescent inﬂammatory bowel
disease who continue to complain of irritable bowel syndrome-like
symptoms (Yiangou et al., 2001; Akbar et al., 2008, 2010). Impor-
tantly, the density of TRPV1-positive nerve ﬁbers in the rectosigmoid
colon correlates with pain severity in both patients with irritable
bowel syndrome and patients with symptomatic but quiescent
inﬂammatory bowel disease (Akbar et al., 2008, 2010).
2.2.4. Therapeutic potential of TRPV1 ligands in the digestive system
Recognition of TRPV1 as a multimodal nocisensor, its sensitization
by a number of proinﬂammatory and proalgesic pathways, its
upregulation under conditions of hyperalgesia and its apparent
implication in experimental colitis have made this TRP channel an
attractive target for novel antinociceptive and antiinﬂammatory drugs
(Szallasi et al., 2007; Holzer, 2008a, 2008b; Voight & Kort, 2010).
Pharmacologically, the function of TRPV1 can be manipulated by two
principal approaches: stimulant/defunctionalizing TRPV1 agonists and
TRPV1 antagonists (Roberts & Connor, 2006; Gharat & Szallasi, 2008;
Gunthorpe & Szallasi, 2008; Baraldi et al., 2010). The mechanism and
result of the two approaches are profoundly different. While TRPV1
antagonists speciﬁcallymodify the functionof the ion channel, stimulant/
defunctionalizing TRPV1 agonists target the cellular function of capsa-
icin-sensitive afferent neurons (Holzer, 1991; Szallasi et al., 2007).
The “desensitization” that is brought about by capsaicin, resinifer-
atoxin or non-pungent TRPV1 ligands reﬂects “defunctionalization”
of the whole afferent neuron expressing TRPV1 for a prolonged
period of time.
At present, there is only evidence for a beneﬁcial effect of
stimulant/defunctionalizing TRPV1 agonists in GI disease. Acute
ingestion of capsaicin has a protective effect against aspirin-induced
erosions in the gastric mucosa of human volunteers (Yeoh et al.,
1995). In addition, capsaicin can improve esophageal motility in
patients with gastro-esophageal reﬂux disease (Grossi et al., 2006).
Prolonged intake of capsaicin appears to desensitize afferent nerve
ﬁbers against noxious stimulation of the upper GI tract. Thus,
ingestion of capsaicin (0.25 mg) capsules by healthy volunteers 3
times per day for 4 weeks blunts the pain response evoked by
duodenal capsaicin administration and balloon distension (Führer &
Hammer, 2009). Similarly, treatment of patients suffering from
functional dyspepsia with capsaicin-containing capsules for 5 weeks
leads to a signiﬁcant reduction of pain symptoms (Bortolotti et al.,
2002). Since there is some information that the prevalence of
heartburn symptoms is low in Asian countries in which the intake
of chili-rich food is common, it has been proposed that chronic
ingestion of capsaicin may be beneﬁcial in patients with gastro-
esophageal reﬂux disease and functional dyspepsia (Gonlachanvit,
2010).
A great deal of effort has been put into developing compounds that
block TRPV1 activation in a competitive or noncompetitive manner
(Gharat & Szallasi, 2008; Gunthorpe & Szallasi, 2008; Kym et al., 2009;
Wong & Gavva, 2009; Voight & Kort, 2010). Some TRPV1 blockers
exhibit species differences in their activity and/or act in a stimulus-
speciﬁc manner, i.e., differentially inhibit the activation of TRPV1 by
capsaicin, heat, and acid (Gavva et al., 2005; Lehto et al., 2008). The
design of stimulus-speciﬁc blockers is of particular importance
because a number of TRPV1 antagonists turned out to have a
pronounced hyperthermic effect that limits their clinical usefulness
(Caterina, 2008; Gavva, 2008; Holzer, 2008b; Romanovsky et al.,
2009;Wong & Gavva, 2009). Apart from their thermoregulatory perils
(Caterina, 2008), TRPV1 antagonists are liable to impair the
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Furthermore, blockade of TRPV1 will interfere with the physiological
role of this nocicensor in surveying the physical and chemical
environment and, if necessary, in initiating protective responses.
Such a role is obvious in the GI tract in which capsaicin-sensitive
afferent neurons constitute a neural alarm system which helps
maintaining mucosal homeostasis in the face of pending injury
(Holzer, 1998, 2004; Akiba et al., 2006b). Other caveats are posed by
the incomplete analysis of the involvement of TRPV1 in GI disease. For
instance, the upregulation of TRPV1 in gut disorders does not
necessarily reﬂect a causal implication of TRPV1 but may equally
well mirror an epiphenomenon of the disease process (Holzer,
2008a).
There are several opportunities to design TRPV1 blockers such that
they can be speciﬁcally targeted at aberrantly expressed or aberrantly
operating TRPV1 channels (Holzer, 2008b) while sparing their
physiological function. These opportunities include the development
of modality-speciﬁc TRPV1 blockers, of uncompetitive TRPV1 antag-
onists, of compounds that selectively address certain TRPV1 splice
variants that may be particularly disease-relevant, compounds that
prevent TRPV1 sensitization, and compounds that prevent the
recruitment and trafﬁcking of TRPV1 to the cell membrane (Gavva,
2008; Holzer, 2008b; Romanovsky et al., 2009). If these approaches
turn out to be successful, TRPV1 blockers may enjoy a wide spectrum
of usefulness in GI disease which includes, pain, hyperalgesia and
inﬂammation associated with gastro-esophageal reﬂux disease,
inﬂammatory bowel disease, functional Gi disorders including
functional dyspepsia and irritable bowel syndrome, disturbances of
GI motor activity, and nausea and emesis.
2.3. TRPV2 and TRPV3 channels
2.3.1. Occurrence of TRPV2 and TRPV3 in the alimentary canal
TRPV2 has been localized to rodent DRG and nodose ganglion
neurons supplying the GI tract (Caterina et al., 1999; Kashiba et al.,
2004; Zhang et al., 2004; Stotz et al., 2008; Zhao & Simasko, 2010;
Zhao et al., 2010). In contrast to TRPV1, TRPV2 occurs primarily in
medium and large diameter afferent neurons (Zhang et al., 2004). In
the rat oral mucosa, TRPV2 is not only present in subepithelial nerve
ﬁbers, but also in junctional epithelial cells surrounding each tooth,
Langerhans cells, dendritic cells, macrophages and endothelial cells of
venules, but not in oral epithelial cells (Shimohira et al., 2009). In the
rat and guinea-pig small intestine, TRPV2 is found in nerve ﬁbers
within the muscularis and myenteric plexus as well as in myenteric
cell bodies (Kashiba et al., 2004; Zhang et al., 2004). In addition,
TRPV2 occurs in the β-cells of murine pancreatic islets and in the
insulinoma cell line MIN6 (Hisanaga et al., 2009). Immunohistochem-
istry of human tissues has localized TRPV2 to epithelial cells of the
salivary glands, pancreatic duct, stomach, duodenum and colon
(Kowase et al., 2002).
TRPV3 is highly expressed by epithelial cells in the nose and tongue
(Xu et al., 2006). It likewise occurs in DRG and nodose ganglion neurons
(Zhang et al., 2004; Stotz et al., 2008; Zhao & Simasko, 2010; Zhao et al.,
2010), but retrograde labeling has failed to identify TRPV3 in vagal
afferent neurons supplying the murine stomach (Zhang et al., 2004).
However, the muscle and mucosa of the murine stomach and small
intestine do contain TRPV3 mRNA (Zhang et al., 2004). In addition,
TRPV3 is expressed by superﬁcial epithelial cells of the murine distal
colon, but not by superﬁcial epithelial cells of the stomach, duodenum
and proximal colon (Ueda et al., 2009).
2.3.2. Functional implications of
TRPV2 and TRPV3 in the digestive system
2.3.2.1. Sensory modalities of TRPV2 and TRPV3. In terms of their
thermosensory modalities, TRPV2 and TRPV3 belong to the group ofthermo-TRP channels because they are activated by speciﬁc temper-
atures (Dhaka et al., 2009). While TRPV2 is typically stimulated by
temperatures above 52 °C (Caterina et al., 1999), TRPV3 responds to
temperatures in the innocuous physiological range (Bandell et al.,
2007). TRPV2 and in particular TRPV3 are sensitive to a variety of
chemical entities and—together with TRPA1, TRPM8 and TRPV1—
TRPV3 is one of the multimodal spice sensors (Table 1). Noteworthy,
TRPV3 is activated by a range of monoterpenoid compounds (Vogt-
Eisele et al., 2007) including carvacrol (oregano), thymol (thyme) and
menthol (mint), although these compounds are also recognized by
other TRP channels such as TRPA1 and TRPM8.
2.3.2.2. Emerging role of TRPV2 and TRPV3 in digestion. The expression
of TRPV2 and TRPV3 in the oral cavity, nose and tongue together with
their sensory modalities suggests that these TRP channels play a role
in probing food for its thermal and chemical qualities. Speciﬁc
implications of TRPV2 and TRPV3 in the GI tract have not yet been
explored. There is evidence, however, that TRPV2 plays a role in the
autocrine regulation of pancreatic β-cells, since insulin causes
translocation and insertion of TRPV2 into the plasma membrane and
the insulin-evoked calcium entry is prevented by TRPV2 inhibition or
knockdown (Hisanaga et al., 2009). In addition, the release of insulin
induced by a high glucose concentration depends on TRPV2.
2.3.3. Association of TRPV3 with gastrointestinal disease
A study analyzing a possible association between genetic variabil-
ity (as examined for 392 single-nucleotide polymorphisms) in 43 fatty
acid metabolism-related genes and risk for colorectal cancer in 1225
patients with cancer and 2032 controls has shown that TRPV3 is
associated with a higher risk for development of colorectal cancer
(Hoeft et al., 2010).
2.4. TRPV4 channels
2.4.1. Occurrence of TRPV4 in the alimentary canal
In the GI tract, TRPV4 occurs primarily in ﬁbers of extrinsic primary
afferent neurons, although some epithelial and other cells have also
been reported to stain positively for this TRPV channel subunit. TRPV4
is present in the nodose ganglion, DRG, stomach, small intestine and
colon of rodents (Zhang et al., 2004; Grant et al., 2007; Cenac et al.,
2008; Brierley et al., 2008; Zhao & Simasko, 2010; Zhao et al., 2010).
Retrograde labeling shows that vagal afferent neurons projecting to
the murine forestomach contain TRPV4 and that, in these neurons,
TRPV4 is coexpressed with TRPV1, TRPV2 and TRPA1 to various
degrees (Zhang et al., 2004). Similarly, DRG neurons projecting to the
murine pancreas synthesize both TRPV4 and TRPA1 (Ceppa et al.,
2010). The expression of TRPV4 in the DRG neurons that project to the
murine and human intestine viamesenteric and pelvic nerves exhibits
pronounced regional differences (Brierley et al., 2008; Cenac et al.,
2008; Sipe et al., 2008). Thus, TRPV4 is particularly abundant in DRG
neurons supplying the colon, in which it is coexpressed with CGRP
(Brierley et al., 2008; Cenac et al., 2008; Sipe et al., 2008). In the
human colon, TRPV4 is found in ﬁne nerve ﬁbers associated with
blood vessels in the submucosa and serosa, while the myenteric
plexus, the circular and the longitudinal smooth muscles are largely
negative (Brierley et al., 2008).
In the murine colon, TRPV4 occurs in brush-bordered epithelial
cells, but not in mucus-secreting epithelial cells, as well as in mucosal
glial cells and unidentiﬁed cells of the submucosal and muscular
layers (Cenac et al., 2008; D'Aldebert et al., 2011). TRPV4 is likewise
expressed by epithelial cells of the human colon and by the human
colon carcinoma cell line Caco-2 (D'Aldebert et al., 2011).
A further location of TRPV4 is in the hepatobiliary tract in which it
is expressed by ciliated cholangiocytes, as shown for both the rat,
murine and human liver and bile system (Gradilone et al., 2007,
2010). In these cells, TRPV4 occurs speciﬁcally in the apical membrane
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osmosensory role (Gradilone et al., 2007).
2.4.2. Functional implications of TRPV4 in the digestive system
2.4.2.1. Sensory modalities of TRPV4. The sensory modalities of TRPV4
(Table 1) include strong acidosis, hypotonicity, warmth, mechanical
stimuli such as distension of the gut, 5,6-epoxyeicosatrienoic acid (an
endogenously formed metabolite of arachidonic acid), and the
synthetic phorbol ester 4-α-phorbol 12,13-didecanoate (Güler et al.,
2002; Mizuno et al., 2003; Suzuki et al., 2003; Nilius et al., 2007).
Although it has been surmised that the mechanosensory function of
TRPV4 reﬂects a secondary transducer role, a patch-clamp study
indicates that TRPV4 is a primary detector of mechanical forces
(Loukin et al., 2010).
2.4.2.2. Role of TRPV4 in gastrointestinal pain and hyperalgesia. TRPV4
has turned out to play a major role in mechanical pain and
hyperalgesia in the colon. TRPV4 agonists excite colonic afferent
neurons in the mouse (Sipe et al., 2008) and enhance the mechan-
osensory responses of colonic serosal and mesenteric afferent nerve
ﬁbers, while the mechanosensitivity of these high-threshold afferent
nerve ﬁbers is substantially attenuated in TRPV4 knockout mice
(Brierley et al., 2008). The TRPV4 agonist-evoked sensitization of
colonic afferent nerve ﬁbers to mechanical stimuli is associated with
mechanical hyperalgesia, as the visceromotor response to colorectal
distension is enhanced (Cenac et al., 2008; Sipe et al., 2008). Vice
versa, TRPV4 knockout or intravertebral pretreatment of mice with
TRPV4-directed small interfering RNA (siRNA) reduces the viscer-
omotor response to colonic distension in the noxious range (Brierley
et al., 2008; Cenac et al., 2008). Taken these ﬁndings together, the
speciﬁc contribution to colonic high-threshold mechanosensory
function makes TRPV4 currently the only nociceptor-speciﬁc TRP
channel in the gut (Blackshaw et al., 2010).
TRPV4 and PAR-2 are colocalized in spinal afferent neurons (Grant
et al., 2007; Sipe et al., 2008), in which these two entities interact with
each other to cause mechanical hyperalgesia in the murine colon
(Cenac et al., 2008; Sipe et al., 2008). Thus, the excitatory effect of
TRPV4 stimulation on ﬁring of colonic afferents is increased by a PAR-
2 agonist (Sipe et al., 2008), and a subnociceptive dose of a PAR-2
agonist is able to sensitize colonic afferents to a subnociceptive dose of
a TRPV4 agonist (Cenac et al., 2008). Activation of PAR-2 likewise
evokes discharge of action potentials in colonic afferent nerve ﬁbers
and enhances the visceromotor response to colorectal distension.
These effects of PAR-2 agonism are absent in TRPV4 knockout mice
(Sipe et al., 2008) as well as after pretreatment with TRPV4 siRNA
(Cenac et al., 2008).
Based on these ﬁndings it is inferred that TRPV4 plays two distinct
roles in colonic pain and hyperalgesia. Under basal conditions, TRPV4
is involved in mechanical nociception, and in this capacity is likely to
operate as primarymechanodetector. In addition, TRPV4mediates the
mechanical hyperalgesia evoked by PAR-2 agonism. In this instance,
TRPV4 seems to act as secondary transducer of PAR-2, a conclusion
that is consistent with the observation that this secondary transducer
role of TRPV4 is not conﬁned to PAR-2. Thus, 5-HT and histamine can
likewise enhance the expression of TRPV4 in DRG neurons projecting
to the murine colon and are able to increase the ability of TRPV4
agonism to induce mechanical hyperalgesia (Cenac et al., 2010).
Importantly, the colonic hypersensitivity to colorectal distension
evoked by 5-HT or histamine is attenuated by TRPV4 siRNA (Cenac
et al., 2010).
In DRG neurons projecting to the murine colon, TRPV4 is not only
colocalized with PAR-2 but also with PAR-4 (Augé et al., 2009). Unlike
PAR-2 agonism, activation of PAR-4 counteracts mechanical pain and
hyperalgesia. Thus, the excitation of DRG neurons by PAR-2 and
TRPV4 agonists is reduced and the ensuing mechanical hypersensi-tivity to colonic distension is attenuated by a PAR-4 agonist (Augé
et al., 2009).
TRPV4 is also likely to contribute to the pain associated with
pancreatitis. Intraductal administration of a TRPV4 agonist to the
murine pancreas causes expression of c-Fos in the spinal cord (Ceppa
et al., 2010). Deletion of the TRPV4 gene inhibits the input to the
spinal cord and the pain behavior associated with experimental
pancreatitis due to caerulein (Ceppa et al., 2010).
2.4.2.3. Role of TRPV4 in the gastrointestinal mucosa and hepatobiliary
system. Emerging evidence attributes TRPV4 a proinﬂammatory role
in the colonic mucosa. Exposure of Caco-2 cells and the human
intestinal epithelial cell line T84 to the TRPV4 agonist 4-α-phorbol
12,13-didecanoate increases the intracellular calcium concentration
and causes release of chemokines (D'Aldebert et al., 2011). In keeping
with these effects, intraluminal administration of the TRPV4 agonist
to the murine colon evokes a transient increase in paracellular
permeability and colitis (D'Aldebert et al., 2011). Furthermore,
the expression of TRPV4 in epithelial cells of the colon is signiﬁcantly
enhanced in mice with DSS-induced colitis (D'Aldebert et al., 2011).
Hypotonicity causes an increase in the intracellular calcium in
cultured murine cholangiocytes and rat intrahepatic bile duct units, a
response that is mimicked by a TRPV4 agonist and impaired by TRPV4
knockdown (Gradilone et al., 2007). The hypotonicity-induced
activation of cholangiocytes leads to TRPV4-dependent bicarbonate
secretion, the main determinant of ductal bile formation. This
mechanism operates as well in vivo, since intrabiliary infusion of a
TRPV4 agonist increases luminal bicarbonate secretion and bile ﬂow
in the rat, this effect being prevented by TRPV4 blockade (Gradilone
et al., 2007). In polycystic kidney rats in which mutations in the
polycystic kidney and hepatic disease 1 gene cause cholangiocytes to
undergo hyperproliferation and to form cysts, TRPV4 is overexpressed
and mislocalized in the cholangiocytes, given that TRPV4 is present
intracellularly rather than at the apical membrane and the cilia
(Gradilone et al., 2010). TRPV4 agonists attenuate the growth of
cultured cholangiocytes from polycystic kidney rats and retard the
formation of cysts in culture, whereas the growth of cholangiocytes
from normal rats is not altered (Gradilone et al., 2010).
2.4.3. Association of TRPV4 with gastrointestinal disease
TRPV4 channelopathies are responsible for a number of hereditary
sensory and motor neuropathies as well as diseases with defects in
bone development (Nilius & Owsianik, 2010). Thus, mutations of
TRPV4 are found in congenital distal spinal muscular atrophy and
scapuloperoneal spinal muscular atrophy (two hereditary motor
neuropathies), hereditary motor and sensory neuropathy of type 2C
(also known as Charcot–Marie–Tooth disease type 2C) (Auer-
Grumbach et al., 2010; Deng et al., 2010; Landouré et al., 2010)
and other rare motor neuropathies (Zimoń et al., 2010). Diseases
with defective bone development such as metatropic dysplasia,
brachyolmia, spondylo-epiphyseal dysplasia of Kozlowski type,
spondylo-epiphyseal dysplasia of Maroteaux type (pseudo-Morquio
syndrome type 2) and parastremmatic dysplasia are also associated
with TRPV4 channelopathies (Camacho et al., 2010; Loukin et al.,
2010; Nishimura G. et al., 2010).
Although the GI tract is not the prime victim of these diseases,
gastro-esophageal reﬂux has been observed in hereditary sensory
neuropathy of type 1B (Auer-Grumbach, 2008). Little is known,
however, whether the hereditary sensory neuropathies of types 1A,
1B and 1D (Auer-Grumbach, 2008) impact on GI sensation and
nociception, although the available reports do not mention any
conspicuous GI disease phenotype.
TRPV4 in sensory neurons is upregulated in inﬂammatory bowel
disease, and serosal blood vessels in tissues with active colitis are
more densely innervated by TRPV4-positive nerve ﬁbers than in
biopsies from healthy controls (Brierley et al., 2008). Expression of
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likewise upregulated, while the levels of TRPV4 mRNA in mucosal
biopsies taken from patients with inﬂammatory bowel disease have
been found unaltered (D'Aldebert et al., 2011). However, the colonic
mucosa of inﬂammatory bowel disease patients is inﬁltrated by
TRPV4-positive CD45-positive leukocytes which are absent from the
mucosa of healthy controls (D'Aldebert et al., 2011).
In patients with polycystic liver diseases (autosomal-recessive
polycystic kidney disease and autosomal-dominant polycystic kidney
disease) TRPV4 is overexpressed in cholangiocytes, a ﬁnding that is
reproduced in polycystic kidney rats, a model for autosomal-recessive
polycystic kidney disease (Gradilone et al., 2010).
2.4.4. Therapeutic potential of TRPV4 ligands in the digestive system
Taken together, the experimental ﬁndings related to TRPV4
function in the digestive system attribute this TRP channel a
pathophysiological role in inﬂammation, pain, hyperalgesia and
polycystic liver disease. This inference if supported by the over-
expression of TRPV4 in experimental colitis, inﬂammatory bowel
disease and polycystic liver disease. Since TRPV4 appears to be a
commonmediator of mechanical hyperalgesia in the colon, it presents
itself as a novel therapeutic target in patients with abdominal pain. In
addition to their antinociceptive and antihyperalgesic potential,
TRPV4 blockers may be useful as antiinﬂammatory drugs. To the
contrary, TRPV4 agonists seem to be beneﬁcial in polycystic liver
disease in which they can inhibit cholangiocyte proliferation and cyst
formation (Gradilone et al., 2010). Indeed, TRPV4 agonists and
blockers are already on the horizon (Vincent et al., 2009) and await
to be assessed for their therapeutic efﬁcacy and safety.
2.5. TRPV5 and TRPV6 channels
2.5.1. Occurrence of TRPV5 and TRPV6 in the alimentary canal
TRPV5 and TRPV6 are expressed in the mucosa of the human and
rodent small and large intestine (Clapham et al., 2005; Nijenhuis et al.,
2005; Schoeber et al., 2007; Benn et al., 2008; Suzuki et al., 2008;
Fukushima et al., 2009; Peleg et al., 2010). While TRPV5 occurs
primarily in the kidneys, TRPV6 is predominantly expressed in
intestinal epithelial cells and has also been localized to human colon
cancer (Caco-2) cells (Schoeber et al., 2007; Fukushima et al., 2009;
Bartik et al., 2010). In addition, TRPV5 mRNA occurs in rat nodose
ganglion neurons expressing cholecystokinin (CCK) CCK1 receptors
(Zhao & Simasko, 2010), which are likely to project to the GI tract.
2.5.2. Functional implications of
TRPV5 and TRPV6 in the digestive system
TRPV5 and TRPV6 are the most Ca2+-selective members of the TRP
ion channel family, play an important role in intestinal Ca2+
absorption (Clapham et al., 2005; Nijenhuis et al., 2005; Schoeber et
al., 2007; Benn et al., 2008; Suzuki et al., 2008), and undergo calcium-
induced inactivation via a phospholipase C-mediated pathway
(Thyagarajan et al., 2009). The functional roles of TRPV5 and TRPV6
are interconnected with each other, given that TRPV5 knockout mice
upregulate their intestinal TRPV6 expression to compensate for the
negative Ca2+ balance caused by the loss of TRPV5-mediated Ca2+
reabsorption in the kidney (Suzuki et al., 2008). In contrast, TRPV6
knockout mice do not display any compensatory mechanism, which
results in secondary hyperparathyroidism (Benn et al., 2008; Suzuki et
al., 2008).
The expression and function of both TRPV5 and TRPV6 are subject
to regulation by dietary conditions and multiple calciotropic hor-
mones (Nijenhuis et al., 2005; Schoeber et al., 2007; Suzuki et al.,
2008). Calcium deﬁciency in the diet is an important factor that
increases the expression of TRPV6 in the duodenal mucosa ofmice (Ko
et al., 2009). Short chain fatty acids, the fermentation products of
fructooligosaccharides, likewise increase expression of TRPV6 andcalcium absorption in the rat colorectal epithelium as well as in Caco-
2 cells (Fukushima et al., 2009). Curcumin, a polyphenol present in
turmeric, is a ligand of the nuclear vitamin D receptor, activation of
which enhances the expression of TRPV6mRNA in Caco-2 cells (Bartik
et al., 2010).
Parathyroid hormone and 1,25-dihydroxyvitamin D3 are particu-
larly relevant to the expression of TRPV5 and TRPV6 in the intestinal
mucosa (Nijenhuis et al., 2005; Schoeber et al., 2007). In chicken
intestinal epithelial cells, 1,25-dihydroxyvitamin D3 and parathyroid
hormone increase calcium uptake by stimulating a protein kinase A-
mediated pathway to release β-glucuronidase, which in turn activates
TRPV6 (Khanal et al., 2008). Consistent with this secondary trans-
ducer role of TRPV6 is the ﬁnding that the 1,25-dihydroxyvitamin
D3-induced calcium uptake is abolished by TRPV6 siRNA (Khanal
et al., 2008). Innormal humanduodenalmucosaobtainedat endoscopy,
TRPV6 expression is likewise increased following exposure to 1,25-
dihydroxyvitamin D3 (Balesaria et al., 2009). Although there is a close
functional interconnection between vitamin D and intestinal TRPV6,
these factors can also operate independently of each other. Thus, the
1,25-dihydroxyvitamin D3-induced intestinal calcium transport in
the murine duodenum does not entirely depend on TRPV6, because
intestinal calcium uptake also occurs in TRPV6 knockout mice (Benn
et al., 2008). In addition, intestinal calcium absorption and duodenal
TRPV6 expression are upregulated in pregnant and lactating mice even
in the absenceof the nuclear vitaminD receptor (Fudge&Kovacs, 2010).
Other hormones that impact on intestinal calcium absorption include
prolactin which induces TRPV6 mRNA in the rat duodenal epithelium,
synergizes with 1,25-dihydroxyvitamin D3 in enhancing TRPV6
expression and stimulates duodenal calcium transport (Ajibade et al.,
2010).
Calcium homeostasis is disturbed in patients with Crohn's disease
(Huybers et al., 2008). Similarly, heterozygous mice carrying a
deletion in the adenine- and uridine-rich elements of the tumor
necrosis factor gene, considered to be a model for Crohn's disease,
display an increase in bone resorption along with a decrease in
the duodenal expression of TRPV6 mRNA (Huybers et al., 2008).
TRPV6 in the intestinal epithelium also appears to have a bearing on
colon cancer development. Thus, TRPV6 expression is signiﬁcantly
enhanced in the Citrobacter rodentium-induced transmissible murine
colonic hyperplasia model (Peleg et al., 2010). Whereas in the normal
colon TRPV6 is restricted to the apical membrane of absorptive
enterocytes, in the hyperplasia model TRPV6 is also distributed to
the proliferating zone of the colonic crypts, in which it occurs in
the basolateral membrane and perinuclear area of many epithelial
cells (Peleg et al., 2010).When the animals are fed with a calcium-rich
diet, the overexpression of TRPV6 in the hyperplasia model is
reversed.2.5.3. Association of TRPV6 with gastrointestinal disease
Increased levels of colonic TRPV6 are associated with early-stage
colon cancer. Thus, TRPV6 has been found to be overexpressed in 66%
of stage I tumors and in 17% of stage II tumors but is barely detectable
in stages III and IV tumors (Peleg et al., 2010). These results suggest
that aberrant function of TRPV6 is associated with early colon
carcinogenesis but not with frank malignancy (Peleg et al., 2010).
This inference is supported by experiments with the human colon
carcinoma cell line Caco-2, which constitutively express high levels of
TRPV6. Treatment of these cells with TRPV6-speciﬁc siRNA signiﬁ-
cantly reduces TRPV6 mRNA levels by about 50%, which is associated
with a 40% reduction of cell proliferation and a more than twofold
increase in apoptosis (Peleg et al., 2010). Together with experiments
in mice with colon crypt hyperplasia (Peleg et al., 2010), these
ﬁndings indicate that TRPV6 promotes the proliferation of colonic
epithelial cells and may be a pathogenetic factor in the early stages of
colon cancer development.
157P. Holzer / Pharmacology & Therapeutics 131 (2011) 142–1702.5.4. Therapeutic potential of TRPV6 ligands in the digestive system
Pharmacological interference with TRPV6 in the digestive system is
likely to interfere with calcium absorption and bone mineralization as
well as with epithelial cell hyperplasia and early stages of malignancies.
Thus, blockade of TRPV6 can be considered as a measure to prevent and
inhibit the development of colon cancer, but this effect needs to be
balanced against any negative impact on calcium homeostasis.
2.6. TRPA1 channels
2.6.1. Occurrence of TRPA1 in the alimentary canal
In the GI tract, TRPA1 occurs in 3 distinct cellular systems: extrinsic
primary afferent neurons, intrinsic enteric neurons and endocrine
cells of the mucosa.
Primary sensory neurons constitute the most signiﬁcant source of
TRPA1 in the body, given that TRPA1 is abundantly expressed by
trigeminal ganglion, nodose ganglion and DRG neurons (Story et al.,
2003; Zhang et al., 2004; Kobayashi et al., 2005; Anand et al., 2008;
Yang et al., 2008; Brierley et al., 2009; Kondo et al., 2009, 2010; Yu et
al., 2009; Cattaruzza et al., 2010; Ceppa et al., 2010; Hondoh et al.,
2010; Zhao et al., 2010). In rodent and human DRG neurons, especially
in those projecting to the gut, TRPA1 is preferentially expressed by
small and medium diameter cell bodies in which it is colocalized with
TRPV1 and CGRP (Bautista et al., 2005; Kobayashi et al., 2005; Anand
et al., 2008; Brierley et al., 2009; Kondo et al., 2009, 2010; Cattaruzza
et al., 2010; Hondoh et al., 2010; Zhao et al., 2010). Similarly, TRPA1
on nodose ganglion neurons in the guinea-pig is primarily associated
with small to medium diameter somata and co-expressed with PAR-2
(Yu et al., 2009). In the periphery, TRPA1 has been found in the
stomach, small intestine, colon and pancreas of the rat andmouse, the
major source being peripheral nerve ﬁbers of DRG and nodose
ganglion neurons (Zhang et al., 2004; Penuelas et al., 2007; Brierley
et al., 2009; Kondo et al., 2009, 2010; Cattaruzza et al., 2010; Ceppa
et al., 2010; Dong Y. et al., 2010). The distribution of TRPA1 in the
rodent gut is similar to that in the canine gut, given that TRPA1 is
strongly expressed in the stomach, pancreas, small intestine and colon
of the dog (Doihara et al., 2009a).
The other sources of TRPA1 in the GI tract are neurons of the
human and murine enteric nervous system (Penuelas et al., 2007;
Anand et al., 2008) as well as 5-HT-releasing enterochromafﬁn cells
and CCK-releasing endocrine cells of the human, rat and murine GI
mucosa (Purhonen et al., 2008; Nozawa et al., 2009). The murine
neuroendocrine cell line STC-1, the rat endocrine cell line RIN14B and
the human pancreatic endocrine cell line QGP-1, which contain
enterochromafﬁn cell markers, likewise express TRPA1 (Purhonen et
al., 2008; Doihara et al., 2009c; Nozawa et al., 2009).
2.6.2. Functional implications of TRPA1 in the digestive system
2.6.2.1. Sensory modalities of TRPA1. TRPA1 was originally identiﬁed as
a cold-activated channel (Story et al., 2003), a role that later provoked
some controversy as TRPM8 is attributed a greater role in this respect
than TRPA1 (Kwan et al., 2006; Bandell et al., 2007; Karashima et al.,
2009; Knowlton et al., 2010). Most remarkable, however, is that
TRPA1 turned out to be a multimodal sensor not only for various
spices but also for an extensive list of endogenous and exogenous
irritant chemicals including a number of drugs in clinical use
(Table 1). Many of these pungent and irritating chemicals are reactive
electrophiles which need to be recognized and avoided because of
their potential to damage tissues through modiﬁcation of nucleic
acids, proteins and other biomolecules (Kang et al., 2010).
Its sensory modalities (Table 1) place TRPA1 speciﬁcally in a
position (1) to taste spicy compounds present in mustard, horserad-
ish, wasabi, galangal, black pepper, garlic, onion, cinnamon, ginger,
oregano, wintergreen and clove (Table 1), (2) to detect toxic
environmental stimuli (Table 1) such as ozone, tear gas, nicotine,formaldehyde, acrolein, iodoacetamide, methyl p-hydroxybenzoate
(an antibacterial added to food, pharmaceutical and cosmetic
products), irritating drugs (e.g., acetaminophen metabolites, fena-
mate nonsteroidal antiinﬂammatory drugs, isoﬂurane, propofol,
dihydropyridines, and clotrimazole), and industrial chemicals (e.g.,
methyl isothiocyanate, and styrene), and (3) to survey the alimentary
canal for potentially deleterious conditions arising from the presence
of alkalosis (Fujita et al., 2008), H2S, nitric oxide, and oxidative insult
products such as 4-hydroxy-2-nonenal, H2O2, and acetaldehyde
(Table 1).
Although there is emerging evidence that TRPA1 contributes to
mechanosensation in the gut (Brierley et al., 2009), it appears that
TRPA1 does not operate as primary mechanosensor. The slowly
adapting currents which indentation of the soma membrane causes
primarily in isolectin B4-negative DRG neuron cultures are suppressed
by the TRPA1 blocker HC-030031 and are absent in TRPA1 knockout
mice (Vilceanu & Stucky, 2010). Analysis of TRPA1-transfected
HEK293 cells, however, shows that TRPA1 alone is not sufﬁcient to
confer mechanical sensitivity (Vilceanu & Stucky, 2010). It would
appear, therefore, that TRPA1 functions as a secondary transducer of
primary mechanosensors that await to be identiﬁed.
2.6.2.2. Sensory function of TRPA1 in the digestive system. In the oral
cavity, TRPA1mediates the taste of many spices (Table 1) and appears
to contribute to the stinging and pungent sensations caused by carbon
dioxide and carbonated beverages (Wang et al., 2010). Once it enters
sensory nerve ﬁbers, carbon dioxide causes intracellular acidiﬁcation,
which in turn activates TRPA1 (Wang et al., 2010).
Many studies have shown that activation of TRPA1 in the
esophagus and GI tract causes excitation of primary afferent neurons
in the vagus, splanchnic and pelvic nerves. TRPA1 agonists such as
allyl isothiocyanate (AITC) excite vagal afferent C-ﬁbers, but not Aδ-
ﬁbers, in the guinea-pig esophagus (Yu & Ouyang, 2009) and spinal
afferent neurons in the murine colon (Cattaruzza et al., 2010).
Accordingly, intracolonic administration of TRPA1 agonists to rodents
induces c-Fos expression in the spinal cord (Cattaruzza et al., 2010;
Mitrovic et al., 2010) and elicits nociception as deduced from the
occurrence of a visceromotor response (Yang et al., 2008) and referred
pain (Laird et al., 2001). Intraductal administration of a TRPA1 agonist
to the murine pancreas likewise causes expression of c-Fos in the
spinal cord (Ceppa et al., 2010). These nociceptive reactions to TRPA1
stimulation in the digestive system are inhibited by the TRPA1 blocker
HC-030031 (Mitrovic et al., 2010), by intrathecal pretreatment with a
TRPA1 antisense oligodeoxynucleotide (Yang et al., 2008) or by TRPA1
gene knockout (Brierley et al., 2009; Cattaruzza et al., 2010; Ceppa
et al., 2010).
TRPA1 is required for normal mechano- and chemosensory
function in distinct subsets of vagal, splanchnic and pelvic afferent
neurons supplying the murine GI tract (Brierley et al., 2009).
Speciﬁcally, spike discharges in response to punctate mechanical
stimulation in splanchnic afferents with receptive ﬁelds in the
mesentery and serosa and in pelvic afferents with receptive ﬁelds in
the mucosa, muscularis and serosa are attenuated in TRPA1 knockout
mice, while the responses of pelvic afferents to muscle stretch remain
unabated (Brierley et al., 2009). Despite these ﬁndings there is at
present uncertainty as to whether TRPA1 contributes to normal
mechanonociception in the colon, given that the visceromotor
response to noxious colorectal distension has been reported to be
reduced (Brierley et al., 2009) or to remain unchanged (Cattaruzza et
al., 2010) in TRPA1 knockout mice. In contrast, there is pharmaco-
logical evidence that in the rat stomach TRPA1 plays a role in
mechanical nociception, given that the pseudoaffective pain reaction
(contraction of the acromiotrapezius muscle) to gastric distension is
attenuated by intrathecal administration of a TRPA1 antisense
oligodeoxynucleotide as well as by intrathecal or intraperitoneal
injection of HC-030031 (Kondo et al., 2009, 2010).
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there is evidence that the two TRP channels interact with each other in
the sensory function of peripheral nerve ﬁbers (Salas et al., 2009; Patil
et al., 2010). For instance, the mechanical desensitization which
capsaicin induces in splanchnic, but not pelvic, colonic afferents is
absent in TRPA1 knockout mice, while the excitatory effect of capsaicin
on these nerve ﬁbers remains unaltered by TRPA1 gene deletion
(Brierley et al., 2009). The interaction between TRPV1 and TRPA1 is
thought to be related to phosphatidyl 4,5-bisphosphate which is a
factor relevant to the function of both TRP channels (Brierley et al.,
2009).
2.6.2.3. Role of TRPA1 in visceral hypersensitivity. In addition to
stimulating afferent neurons, TRPA1 agonists sensitize colonic sensory
neurons to mechanical stimulation (Brierley et al., 2009) and enhance
the visceromotor response to colorectal distension (Cattaruzza et al.,
2010), these effects being prevented by TRPA1 gene knockout or HC-
030031. The ability of AITC to sensitize mechanosensitive afferent
neurons may be related to its effect to enhance the level of TRPA1 in
the colon (Kimball et al., 2007). This argument is supported by a study
in which AITC-induced irritation of the colon in newborn mouse pups
results in a long-lasting hypersensitivity to colorectal distension as
examined in the grown-up animals (Christianson et al., 2010). The
enhanced visceromotor response to colorectal distension seen in
these experiments is thought to be driven by an early increase in
colonic neurotrophin expression, which leads to a permanent increase
in the percentage of TRPA1-positive DRG neurons, whereas the
number of TRPV1-positive DRG cells remains unaltered (Christianson
et al., 2010).
There is substantial evidence that TRPA1 contributes to the GI
mechanical hypersensitivity that is associated with GI inﬂammation
and stress. For instance, colitis induced by trinitrobenzene sulfonic
acid (TNBS) in rats causes upregulation of TRPA1 in DRG neurons
innervating the rat colon and enhances the visceromotor response to
colorectal distension, this effect being reduced by intrathecal
pretreatment with a TRPA1 antisense oligodeoxynucleotide (Yang
et al., 2008). Likewise, the effect of TNBS-induced colitis to enhance
spinal neuron activation and the visceromotor pain reaction to
colorectal distension is absent in TRPA1 knockout mice (Cattaruzza
et al., 2010). This observation is consistent with the ability of TNBS-
induced colitis to increase the ability of TRPA1 agonists to sensitize
mechanosensitive afferents in the splanchnic and pelvic nerves
(Brierley et al., 2009). Apart from GI inﬂammation, stress is also
known to give rise to visceral hypersensitivity. The abdominal
withdrawal reﬂex to colorectal distension, which is enhanced
following chronic exposure to water avoidance stress for 10 days, is
associated with a signiﬁcant upregulation of TRPA1 in DRG neurons
supplying the colon (Yu et al., 2010), but it has not yet been
demonstrated whether TRPA1 is causally involved in stress-evoked
visceral hyperalgesia.
Under conditions of inﬂammation, TRPA1 appears to take over a
signiﬁcant role as secondary transducer of several proinﬂammatory
mediators such as bradykinin and endogenous PAR-2 agonists.
Pharmacological and gene knockout experiments indicate that
TRPA1 mediates the bradykinin-induced mechanical sensitization of
splanchnic afferents innervating the colonic serosa of the mouse
(Brierley et al., 2009) and the bradykinin-evoked mechanical
hypersensitivity of vagal afferent neurons in the guinea-pig esopha-
gus (Yu & Ouyang, 2009). Importantly, the activation of vagal and
splanchnic afferents by bradykinin itself is independent of TRPA1
(Brierley et al., 2009; Yu & Ouyang, 2009). Mast cell activation and
activation of PAR-2 are further stimuli that cause mechanical
hypersensitivity of vagal afferent neurons in the guinea-pig esopha-
gus via a TRPA1-dependentmechanism (Yu et al., 2009). Similarly, the
ability of a PAR-2 agonist to enhance the visceromotor response to
colorectal distension is abrogated by TRPA1 gene deletion (Cattaruzzaet al., 2010), while the effect of a PAR-2 agonist to stimulate colonic
afferents in the splanchnic nerves per se is unaltered in TRPA1
knockout mice (Brierley et al., 2009).
The role of TRPA1 is not limited to mechanical hypersensitivity, as
TRPA1 also participates in inﬂammation-evoked chemical hypersen-
sitivity in the digestive system. Induction of mild colitis with DSS
causes colonic hypersensitivity to AITC as revealed by increased
expression of c-Fos in the murine spinal cord (Mitrovic et al., 2010).
This hyperresponsiveness to colonic TRPA1 stimulation is prevented
by HC-030031 as well as by morphine, which suggests that the spinal
c-Fos response to colonic TRPA1 stimulation reﬂects colonic chemo-
nociception (Mitrovic et al., 2010). Similarly, TNBS-induced colitis in
the rat ampliﬁes the visceromotor response to intracolonic AITC in a
TRPA1 antisense oligodeoxynucleotide-sensitive manner (Yang et al.,
2008). TNBS-evoked colitis is associated with an upregulation of
TRPA1 in DRG neurons supplying the colon (Yang et al., 2008), an
effect that may involve neurotrophic factors formed under conditions
of irritation and inﬂammation (Anand et al., 2008; Christianson et al.,
2010).
2.6.2.4. Role of TRPA1 in inﬂammation within the digestive system. AITC
has long been used to elicit and examine neurogenic inﬂammation
(Holzer, 1988), and there is evidence that activation of TRPA1 on
visceral sensory neurons gives rise to both vasodilatation (Pozsgai et
al., 2010) and inﬂammation (Kimball et al., 2007; Ceppa et al., 2010).
Introduction of excess AITC into the murine colon induces colitis
which is associatedwith an upregulation of TRPA1 and other factors of
the intestinal nervous and immune systems (Kimball et al., 2007).
Similarly, intraductal administration of an AITC agonist to the murine
pancreas causes inﬂammation and activation of spinal neurons, these
effects being markedly attenuated in TRPA1 knockout mice (Ceppa
et al., 2010). The pancreatitis evoked by caerulein is likewise
ameliorated by TRPA1 deletion, as is the activation of spinal neurons
and the pain behavior that accompany pancreatitis (Ceppa et al.,
2010). Neurogenic inﬂammation does not necessarily have a
deleterious effect on the tissue, given that AITC has a protective effect
against experimentally induced gastric lesions in the rat, an effect that
appears to involve endogenous prostaglandins (Matsuda et al., 2007).
The inhibitory effect which AITC and icilin have on the restitution of
wounded monolayers of the rat gastric epithelial cell line RGM1 does
not seem to be mediated by TRPA1 (Hayashi et al., 2008).
2.6.2.5. Role of TRPA1 in the gastrointestinal endocrine system.
Stimulation of TRPA1 on the murine neuroendocrine cell line STC-1
causes cell activation and release of CCK (Purhonen et al., 2008), and
activation of TRPA1 on rat enterochromafﬁn cells, on the rat endocrine
cell line RIN14B and on the human pancreatic endocrine cell line QGP-
1 leads to release of 5-HT (Doihara et al., 2009c; Nozawa et al., 2009).
These effects of TRPA1 stimulation may be of functional relevance if
the broad sensory spectrum of both TRPA1 and GI endocrine cells and
the functional implications of CCK and 5-HT in digestion and GI
signaling to the brain are considered. However, these implications of
TRPA1 await to be explored and analyzed both in vitro and in vivo.
2.6.2.6. Role of TRPA1 in gastrointestinal motor function. Stimulation of
TRPA1 in the gut has distinct effects on GI motor activity, the effects of
TRPA1 stimulation being region- and species-dependent. Although
intracolonic AITC (2.5%) does not alter compliance of themurine colon
in vivo (Cattaruzza et al., 2010), isolated segments of the murine
colon, but not small intestine, contract in response to AITC (30–
100 μM) and allicin, the response being depressed by tetrodotoxin
throughout the colon, whereas atropine inhibits the AITC-induced
contraction in the distal colon only (Penuelas et al., 2007). In the
guinea-pig ileum, AITC is able to evoke contraction via a mechanism
that involves 5-HT and activation of 5-HT3 receptors, which suggests
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an impact on the control of intestinal motility (Nozawa et al., 2009).
While the effect of TRPA1 stimulation in the intestine is to facilitate
motor activity, gastric emptying in the rat in vivo is delayed by the
TRPA1 agonists AITC and cinnamaldehyde through an action that also
involves 5-HT and activation of 5-HT3 receptors (Doihara et al.,
2009b). Administration of TRPA1 agonists to the dog in vivo
stimulates motor activity in the gastric antrum and jejunum, and
elicits giant migrating contractions in the colon (Doihara et al.,
2009a). Activation of TRPA1 also has a prokinetic effect in the murine
colon, in which AITC is able to antagonize atonic constipation induced
by clonidine as well as spastic constipation induced by loperamide
(Kojima et al., 2009). However, the physiological implications of
TRPA1 in the nerve circuits and smooth muscle mechanisms
governing GI motility remain largely unexplored. Indirect evidence
suggests that TRPA1 participates in the cold-induced contraction of
the rat colon (Dong Y. et al., 2010), but the physiological relevance of
this ﬁnding is not yet possible to judge.
2.6.3. Association of TRPA1 with gastrointestinal disease
A point mutation in the S4 transmembrane segment of the TRPA1
gene appears to be responsible for an autosomal-dominant familial
episodic pain syndrome that is triggered by fasting and physical stress
(Kremeyer et al., 2010). Functional analysis shows that this mutation in
the TRPA1 channel is associated with a 5-fold increase in inward current
following activation and with enhanced secondary hyperalgesia caused
by AITC (Kremeyer et al., 2010). It awaits to be explored whether
function-relevantmutations in the TRPA1 gene are relevant to GI disease.
2.6.4. Therapeutic potential of TRPA1 ligands in the digestive system
The properties of TRPA1 as a multimodal sensor for a huge variety
of irritant chemicals (Table 1) indicate that TRPA1 blockers could be
used tomanage chemical irritation and pain. In addition, the emerging
pathophysiological implications of TRPA1 suggest that both TRPA1
agonists and blockers hold therapeutic potential in particular disease
entities. There is good reason to surmise that TRPA1 blockers could be
of particular beneﬁt in inﬂammation-induced hyperalgesia in the GI
tract. TRPA1 blockers may also be of use in pancreatitis (Ceppa et al.,
2010) and inﬂammatory bowel disease. The discovery that activation
of TRPA1 by some drugs contributes to their adverse effect proﬁle
(Table 1), whichmay include the alimentary canal, provides a rational
basis for developing drugs that lack this unwanted property.
TRPA1 blockers such as HC-030031 have already been character-
ized, and many other compounds are in the pipeline (Baraldi et al.,
2010). The interaction between TRPA1 and TRPV1 in the excitation
and/or sensitization of nociceptive nerve ﬁbers (Salas et al., 2009;
Patil et al., 2010) hints at the possibility that combined TRPA1 plus
TRPV1 blockers may have superior efﬁcacy compared with blockers
that target TRPA1 or TRPV1 alone. It awaits to be explored whether
interference with TRPA1 disturbs temperature homeostasis, as it has
been found with TRPV1 blockers. This limitation cannot be neglected,
given that intragastric administration of the TRPA1 agonists AITC and
cinnamaldehyde increases thermogenesis and reduces heat diffusion
in mice (Masamoto et al., 2009).
Apart from TRPA1 blockers, TRPA1 agonists also may have thera-
peutic potential. The large variety of TRPA1 agonists available to date
(Table 1) can be roughly categorized in two classes: (1) agonists that
stimulate TRPA1 via a transient and reversible interaction with the
channel, and (2) agonists with an electrophilic carbon or sulfur that
bind covalently to cysteine residues of the cytoplasmatic N-terminus
of TRPA1 (Baraldi et al., 2010). A speciﬁc application of TRPA1
agonists is suggested by their prokinetic effect in the murine colon,
which—if translated to humans—could be utilized in the manage-
ment of both atonic and spastic motor stasis of the gut (Kojima et al.,
2009). TRPA1 agonists that will be useful in therapy certainly require
optimization in their pharmacological proﬁle, since the utility of thecurrently available TRPA1 agonists is limited by their irritative effects
and high reactivity.
2.7. TRPM4 and TRPM5 channels
2.7.1. Expression of TRPM4 and TRPM5 in the alimentary canal
Expression of TRPM4 and, particularly, TRPM5, is limited to taste,
epithelial and endocrine cells. TRPM4 transcripts have been identiﬁed
in pancreatic α- and β-cell lines of rodent origin (Cheng et al., 2007;
Marigo et al., 2009), and TRPM5 has been localized to pancreatic islets
of the mouse in which it is expressed by the insulin-secreting β cells
(Colsoul et al., 2010). TRPM5 abounds on the receptor cells of the
lingual taste buds as well as on other chemosensory cells, notably on
epithelial taste cells of the gut (Zhang et al., 2003; Bezençon et al.,
2007; Kaske et al., 2007; Kokrashvili et al., 2009). Both TRPM4 and
TRPM5mRNA are found in the human digestive system (Fonfria et al.,
2006). TRPM5 occurs in the stomach, small intestine and colon of mice
and humans, the channel occurring in solitary brush (also termed
tufted or caveolated) cells at the surface epithelium of the small and
large intestine and in endocrine cells of the duodenal glands (Fonfria
et al., 2006; Bezençon et al., 2007, 2008; Kaske et al., 2007; Kokrashvili
et al., 2009; Young et al., 2009). Endocrine cells isolated from the rat
stomach also stain positively for TRPM5 (Nakamura et al., 2010).
2.7.2. Functional implications of
TRPM4 and TRPM5 in the digestive system
Functional evidence suggests that TRPM4 contributes to the
membrane depolarization and increase in the intracellular calcium
concentration that are relevant to glucose-, arginine vasopressin- and
glibenclamide-evoked secretion of insulin from pancreatic β-cells and
perhaps glucagon frompancreaticα-cells (Cheng et al., 2007;Marigo et
al., 2009). TRPM5 is likewise thought to play amajor role in the glucose-
dependent release of insulin from pancreatic β-cells (Brixel et al., 2010;
Colsoul et al., 2010). Speciﬁcally, the effect of glucose to release insulin
is signiﬁcantly reduced in TRPM5 knockout mice, which impairs
glucose tolerance (Brixel et al., 2010; Colsoul et al., 2010).
The Ca2+-gated TRPM5 channel on the receptor cells of the taste
buds in the tongue has been established to contribute to signal
transduction in the sweet, umami and bitter tastes (Zhang et al., 2003;
Damak et al., 2006). Bitter, sweet, and umami tastants bind to GPCRs
which initiate a second-messenger signaling cascade involving
activation of phospholipase Cβ2 and hydrolysis of phosphatidylino-
sitol 4,5-bisphosphate to diacylglycerol and inositol trisphosphate.
The subsequent increase in the intracellular Ca2+ concentration gates
TRPM5 and causes depolarization of the taste cells and chemical
transmission to gustatory afferent neurons (Zhang Z. et al., 2007). Real
life gustatory experiences are often evoked by taste mixtures and
determined by multiple interactions between different taste stimuli
(Talavera et al., 2008). One such interaction is the suppression of
sweet taste transduction by bitter tastants such as quinine. Quinine
and its stereoisomer quinidine have been found to block TRPM5
currents and to inhibit the nerve impulses of sucrose-stimulated
gustatory nerves in mice (Talavera et al., 2008). Since this quinidine-
evoked inhibition of sweet taste signaling is absent in TRPM5
knockout mice, it would appear that TRPM5 plays an important role
in bitter–sweet taste interactions (Talavera et al., 2008).
Apart from their occurrence in lingual taste cells, TRPM5 is widely
expressed by other chemosensory cells, notably by the tufted
epithelial cells of the GI tract (Kaske et al., 2007; Rozengurt &
Sternini, 2007). Given that the TRPM5-positive cells of the gut express
most genes encoding proteins implicated in sweet, bitter, and umami
taste signaling (Bezençon et al., 2008), it would appear that TRPM5
exert taste functions throughout the alimentary canal and contribute
to the surveillance of the chemical composition in its lumen. This
functional implication is corroborated by the ﬁnding that the
expression of TRPM5 in the upper small intestine is inversely
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patients (Young et al., 2009).
Another task of TRPM5-positive taste cells in the digestive system
may be to play local effector roles because they express markers
of neuronal and inﬂammatory cells (Bezençon et al., 2008) and can
release biologically active messengers in response to stimulation.
Solitary chemosensory cells in the upper small intestine of the
murine coexpress TRPM5, β-endorphin, methionine enkephalin and
uroguanylin (Kokrashvili et al., 2009). Stimulation of these cells with
hyperosmolar solutions or glucose causes release of β-endorphin
into the intestinal lumen but not blood serum, an effect that is blunted
in TRPM5 knockout mice (Kokrashvili et al., 2009). In contrast, the
intestinal release of β-endorphin evoked by acidic solutions or lipid
exposure appears to be independent of TRPM5(Kokrashvili et al., 2009).
2.7.3. Therapeutic potential of TRPM5 ligands in the digestive system
Being a transducer of the sweet taste, TRPM5 has been suggested
to have therapeutic potential in the management of obesity and
related metabolic dysfunctions, given that taste signaling is a critical
determinant of ingestive behavior (Sprous & Palmer, 2010). How
efﬁcacious such an approach may be is difﬁcult to judge, however,
because deletion of TRPM5 does not completely abolish the
preference for sweets and energy-rich food. The reason for this
ﬁnding is that there are TRPM5-independent transduction mecha-
nisms for glucose tasting (Ohkuri et al., 2009) and sweet and calorie-
rich nutrients can directly inﬂuence brain reward circuits that control
food intake independently of functional taste transduction (de Araujo
et al., 2008; Ren et al., 2010).
As TRPM5 appears to be involved in glucose-dependent insulin
secretion, TRPM5 dysfunction has been suggested to be a factor in the
etiology of some forms of type 2 diabetes (Brixel et al., 2010). If so,
normalization of TRPM5 function may be envisaged as a target in
diabetes management.
2.8. TRPM6 and TRPM7 channels
2.8.1. Occurrence of TRPM6 and TRPM7 in the alimentary canal
TRPM6 and TRPM7 occur in GI epithelial cells and, as is true for
TRPM7, in ICCs. In the murine gut, TRPM6 and TRPM7 abound in the
brush-border membrane of the colon (Schlingmann et al., 2002; Voets
et al., 2004; Fonfria et al., 2006; Groenestege et al., 2006; Rondón et al.,
2008a, 2008b; Woudenberg-Vrenken et al., 2010). Furthermore,
TRPM7 mRNA and protein are expressed by AGS cells, the most
common human gastric adenocarcinoma cell line (Kim et al., 2008).
Apart from their association with epithelial cells, TRPM7 is present on
ICCs of the myenteric plexus and circular muscle throughout the GI
tract of mice and humans (Kim et al., 2005, 2006, 2009).
2.8.2. Functional implications of
TRPM6 and TRPM7 in the digestive system
Several data suggest that the formation of functional TRPM6
channels in epithelial cell membranes requires co-expression with
TRPM7. There is indeed evidence for the formation of heteromeric ion
channels consisting of both TRPM6 and TRPM7 subunits, but there is
still controversy as to whether TRPM6 can also function on its own
and TRPM7 is required only for trafﬁcking of TRPM6 to the plasma
membrane (Schlingmann et al., 2007; Quamme, 2008). TRPM6 and
TRPM7 possess an atypicalα-kinase domain and are involved inMg2+
homeostasis, given that genetic and functional data indicate that both
channel kinases play a critical role in the cellular Mg2+ absorption
within the GI mucosa (especially in the colon) and in the reabsorption
of Mg2+ in the kidney (Schlingmann et al., 2007; Quamme, 2008;
Woudenberg-Vrenken et al., 2010). Homozygous deletion of TRPM6
inmice is lethal, while heterozygous deletion of TRPM6 results in mild
hypomagnesemia, a deﬁcit that cannot be compensated for by a
magnesium-rich diet (Woudenberg-Vrenken et al., 2010).TRPM6 and TRPM7 channel function and colonic Mg2+ absorption
are in fact controlled by many factors. For instance, the hypomagne-
semia associated with dietary Mg2+ restriction in mice causes
upregulation of TRPM6 expression both in the intestine and kidney
(Rondón et al., 2008a). The expression of TRPM6, but not TRPM7,mRNA
in the colon is likewise enhanced by a Mg2+-rich diet (Groenestege et
al., 2006). Feeding of mice with long-chain inulin for 2 weeks, which
increases Mg2+ absorption and enhances bone stores of Mg2+, results
in a rise of TRPM6 and TRPM7 expression in the hindgut, while TRPM7
in the kidney is down-regulated (Rondón et al., 2008b).
Mg2+ is critical for the growth and survival of certain cancer cells,
notably the human gastric adenocarcinoma cell line AGS (Kim et al.,
2008). Blockade of TRPM7 channels with La3+ or suppression of
TRPM7 expression by siRNA inhibits the growth and survival of AGS
cells (Kim et al., 2008).
In addition to its epithelial function, TRPM7 plays a role in
controlling intestinal motor activity. Electrophysiological, molecular
biological, and immunohistochemical evidence indicates that TRPM7
participates in the nonselective cation current that underlies the
pacemaker activity of ICCs in the GI tract (Kim et al., 2006). Thus, the
electrophysiological and pharmacological properties of the nonselec-
tive cation current in ICCs of the mouse are identical to those of
TRPM7, and the pacemaker activity of ICCs is inhibited by TRPM7-
speciﬁc siRNA (Kim et al., 2005). TRPM7 expressed on ICCs is also
likely to contribute to pacemaker activity in the human gut, since slow
waves in the isolated muscle of the human small and large intestine
are attenuated by blockade of TRPM7 channels with La3+ (Kim et al.,
2009).
2.8.3. Association of TRPM6 with gastrointestinal disease
Non-functional mutations of TRPM6 are responsible for a primary
disorder termed hypomagnesemia with secondary hypocalcemia
(Schlingmann et al., 2002; Voets et al., 2004). The expression of
TRPM6 mRNA in the intestinal epithelium is reduced in patients
suffering from cholera, a change that is thought to counteract the
secretory response to the infection (Flach et al., 2007).
2.8.4. Therapeutic potential of TRPM7 blockers in the digestive system
The ability of TRPM7 channel blockade to inhibit the growth and
survival of AGS cells suggests TRPM7 to be a potential target for the
treatment of gastric cancer (Kim et al., 2008).
2.9. TRPM8 channels
2.9.1. Occurrence of TRPM8 in the alimentary canal
TRPM8 is distributed to several cell types in the digestive system.
Being menthol-sensitive, the TRPM8 subunit is expressed in the
papillae of the tongue as well as by a distinct population of primary
afferent neurons originating in the nodose-petrosal ganglion and DRG
(McKemy et al., 2002; Peier et al., 2002; Zhang et al., 2004; Kobayashi
et al., 2005; Hondoh et al., 2010; Zhao et al., 2010). Unlike that of
TRPA1, the colocalization of TRPM8 with TRPV1 in sensory neurons is
limited (Bautista et al., 2005; Kobayashi et al., 2005; Kondo et al.,
2009; Hondoh et al., 2010; Zhao et al., 2010). Within the GI tract,
TRPM8 has been localized to the muscle of the rat stomach and colon
(Mustafa & Oriowo, 2005) as well as to the liver (Fonfria et al., 2006).
The expression of TRPM8 in the murine stomach and small intestine
remains controversial, given that both positive (Zhang et al., 2004)
and negative (Penuelas et al., 2007) results have been reported.
2.9.2. Functional implications of TRPM8 in the digestive system
TRPM8 is activated by temperatures in the cool to cold range and
makes an important contribution to cold-induced pain (Bautista et al.,
2007; Colburn et al., 2007; Dhaka et al., 2007; Knowlton et al., 2010).
Apart from low temperatures, TRPM8 is stimulated by various
chemical entities including menthol, icilin, geraniol, L-carvone,
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are likely to explain the refreshing taste of menthol. Also keepingwith
this property is the ﬁnding that intragastric administration of the
TRPM8 agonist menthol induces thermogenesis in mice (Masamoto et
al., 2009).
Expressed by extrinsic primary afferent neurons and intrinsic
systems within the GI tract, TRPM8 may play a chemosensory role in
the alimentary canal. This contention is supported by the observation
that themixed TRPA1/TRPM8 agonist icilin is able to stimulate murine
nodose ganglion neurons in culture (Zhang et al., 2004). However,
systematic studies of the chemosensory role of TRPM8-bearing
primary afferent neurons in the gut have not yet been reported, and
the precise functional implications of TRPM8 in the digestive system
await to be explored. In the murine colon, menthol induces a long
lasting relaxation of smooth muscle, which remains unaffected by
tetrodotoxin (Penuelas et al., 2007). It is questionable if this motor
effect of menthol is due to activation of TRPM8 because the presence
of TRPM8 in the murine gut has not unequivocally been established
(Zhang et al., 2004; Penuelas et al., 2007). Whether the cooling-
induced contraction of the rat gastric fundus (Mustafa & Oriowo,
2005) and guinea-pig ileum (Holzer & Lembeck, 1979) involves
TRPM8 has not conclusively been investigated.
2.10. TRPP2 channels
2.10.1. Occurrence of TRPP2 in the alimentary canal
The polycystin TRP channel TRPP2 (also known as polycystic kidney
disease-like ion channel, PKD2L1) and the related PKD1 polycystin L3
(PKD1L3) are expressed by a select class (type III) of taste chemore-
ceptor cells in the murine tongue, which are distinct from those
mediating sweet, umami and bitter tastes (Huang et al., 2006; Ishimaru
et al., 2006; LopezJimenez et al., 2006; Kataoka et al., 2008;
Chandrashekar et al., 2009; Kawaguchi et al., 2010). While TRPP2 has
been reported to occur in the circumvallate, foliate and fungiform
papillae of the tongue and in the palate, PKD1L3 has been localized to
the circumvallate and foliate papillae only (Huang et al., 2006; Ishimaru
et al., 2006). PKD1, the gene that is mutated in ~85% of autosomal
dominant polycystic kidney disease patients, has been described to
occur in many tissues including the intestine (Geng et al., 1997).
2.10.2. Functional implications of TRPP2 in the digestive system
Although several members of the TRPV, TRPA and TRPC channel
subfamilies are sensitive to alterations in extracellular pH (Holzer,
2009), TRPP2 (PKD2L1) is the TRP channel involved in sour taste
transduction (Chandrashekar et al., 2006; Ishimaru & Matsunami,
2009). In order to form functional channels, TRPP2 needs to associate
as heteromer with related proteins of the PKD1 polycystin family such
as PKD1L3 (Ishimaru et al., 2006; Kawaguchi et al., 2010). The PKD1
polycystins are not included in the TRP channel family because they
are large proteins with a very long N-terminal extracellular domain
and 11 transmembrane domains that include a 6-transmembrane
TRP-like channel domain at the C terminus (Clapham et al., 2005).
Both genetic and functional studies corroborate that TRPP2 plays
an important role as sour taste receptor (Huang et al., 2006; Ishimaru
et al., 2006; LopezJimenez et al., 2006; Kataoka et al., 2008; Kawaguchi
et al., 2010). In the taste buds of the murine tongue, TRPP2 is
accumulated at the taste pore region where taste chemicals are
detected. Coexpression of TRPP2 and PKD1L3 is necessary for the
positioning of functional sour taste receptors at the cell surface, which
is the case in the circumvallate and foliate papillae of the murine
tongue (Huang et al., 2006; Ishimaru et al., 2006; Chandrashekar et al.,
2009; Kawaguchi et al., 2010). In native circumvallate taste cells
expressing TRPP2 the pH threshold for acid-induced increases in the
intracellular calcium concentration is around 5.0 (Kawaguchi et al.,
2010). Targeted ablation of TRPP2-expressing taste receptor cells
results in a speciﬁc and total loss of sour taste transduction, whereasresponses to sweet, umami, bitter and salty tastants remain
unchanged (Huang et al., 2006). The relevance of PKD1, which occurs
in the intestine (Geng et al., 1997), to GI function remains unexplored.
The TRPP2-expressing sour taste cells also appear to contribute to
the taste of carbonation. While the principal CO2 taste sensor is
carbonic anhydrase-4 (Chandrashekar et al., 2009), it remains to be
determined whether TRPP2 plays a role in the downstream signaling
of the carbonation taste.
2.11. TRPC channels
2.11.1. Occurrence of TRPC in the alimentary canal
Distinct members of the classical or canonical TRP channels (TRPC)
are widely distributed in the GI tract, the cellular sources being vagal
afferent neurons, enteric neurons, smooth muscle cells, ICCs and
epithelial cells. TRPC1, TRPC3, TRPC5 and TRPC6 have been localized
to nodose ganglion neurons in which TRPC1 and TRPC6 are, at least in
part, coexpressed with TRPV1 and TRPA1. The evidence for this
colocalization rests on the ﬁnding that systemic pretreatment of rats
with a neurotoxic dose of capsaicin causes a loss of TRPV1, TRPA1,
TRPC1 and TRPC6 from vagal afferent neurons (Zhao et al., 2010). In
the mouse DRG, mRNA for all 7 types of TRPC subunits (TRPC1–
TRPC7) has been found, with TRPC1, TRPC3 and TRPC6 being the most
abundant (Elg et al., 2007).
All 7 types of TRPC subunits have likewise been identiﬁed in the
murine stomach (Lee et al., 2003; So & Kim, 2003). TRPC6 is expressed
in human esophageal and gastric epithelial cells (Cai et al., 2009; Shi et
al., 2009), while TRPC1 and TRPC5 have been localized to intestinal
epithelial cells (Rao et al., 2006). In addition, TRPC4, TRPC6 and TRPC7
as well as splice variants of TRPC4 (TRPC4-α and TRPV-β) and TRPC7
are present in GI and vascular smooth muscle of the murine and
canine alimentary canal, TRPC4 being the most abundant subunit
(Walker et al., 2001, 2002; Torihashi et al., 2002; Lee et al., 2005; Kim
et al., 2006; Tsvilovskyy et al., 2009). TRPC1, TRPC3, TRPC4, TRPC5 and
TRPC6 mRNA have likewise been localized to circular muscle cells of
the human esophageal body and lower esophageal sphincter, the
levels of TRPC3 and TRPC4mRNA being higher in the sphincter than in
the body (Wang et al., 2003).
The guinea-pig enteric nervous system expresses TRPC1, TRPC3,
TRPC4 and TRPC6, which are differentially distributed to the
myenteric and submucosal plexuses (Liu et al., 2008). While TRPC1
abounds in myenteric neurons with cholinergic and nitrergic
phenotypes as well as in submucosal cholinergic and noncholinergic
secretomotor neurons, TRPC3 is restricted to submucosal neurons
containing neuropeptide Y (Liu et al., 2008). TRPC4 and TRPC6 are
likewise preferentially expressed by noncholinergic secretomotor
neurons of the submucosal plexus (Liu et al., 2008).
2.11.2. Functional implications of TRPC in the digestive system
The abundant distribution of TRPC channels to vagal afferent
neurons, enteric neurons, smooth muscle cells, ICCs and epithelial
cells in the gut points to multiple functional implications of this class
of TRP channels. However, their role in the neural control of digestive
functions has not yet been examined. There is, however, increasing
evidence that TRPC channels are involved in signal transduction
within the epithelium and smooth muscle of the GI tract. In addition,
distinct TRPC channels play a physiological role in GI epithelial cell
homeostasis and in the development of malignancies.
The phenotype of TRPC1 knockout mice is characterized by a
pronounced impairment of neurotransmitter-stimulated salivary gland
ﬂuid secretion, which suggests that TRPV1 is relevant to the secretory
process in salivary gland acinar cells (Liu et al., 2007). In human colonic
epithelial cells TRPC1 is involved in the signal transduction of the
extracellular calcium-sensing receptor which is relevant to both
intracellular calcium oscillation and inhibition of proliferation (Rey et
al., 2010). Wounding of the mucosa causes translocation of stromal
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TRPC1-mediated calcium inﬂux and promotes intestinal epithelial
restitution (Rao et al., 2010). Induced TRPC1 expression facilitates,
while inhibition of its expression by TRPC1-directed siRNA inhibits
epithelial cell migration after wounding (Rao et al., 2006, 2010). In
addition, induced TRPC1 expression sensitizes intestinal epithelial cells
to apoptosis via calcium inﬂux-mediated inhibition of nuclear factor-κB
activity (Marasa et al., 2006, 2008).
TRPC1 and TRPC6 play a role in pancreatic and GI cancer
development. In the pancreatic cancer cell line BxPc3, TRPC1 is a
transducer of the action of tumor growth factor-β to stimulate cell
motility, a process that is of relevance to tumor cell invasion (Dong H.
et al., 2010). TRPC6, which can be activated both by receptor tyrosine
kinases and GPCRs, appears to have a role in human esophageal and
gastric cancer development (Cai et al., 2009; Shi et al., 2009).
Treatment of the human gastric cancer cell lines AGS and MKN45
with the TRPC channel blocker SKF-96,365 arrests the cell cycle in the
G2/M phase and suppresses the formation of gastric tumors in nude
mice (Cai et al., 2009). Inhibition of TRPC6 likewise arrests the cell
cycle of human esophageal squamous carcinoma cells in the G2 phase
and inhibits tumor formation in nude mice injected with esophageal
squamous carcinoma cells (Shi et al., 2009).
In the exocrine pancreas, TRPC3-mediated calcium inﬂux is
attributed an adverse role in the acute inﬂammation induced by
supramaximal stimulation or exposure to toxic bile acids and
palmitoleic acid ethyl ester (Kim M.S. et al., 2009). Consequently,
deletion of TRPC3 has been found to attenuate experimentally evoked
acute pancreatitis (Kim M.S. et al., 2009).
TRPC channels have been proposed to participate in intestinal
pacemaker activity of ICCswhich through electrical coupling drive slow
wave activity in intestinal smooth muscle. The pacemaker current that
initiates each slow wave derives from a Ca2+-inhibited, voltage-
independent, nonselective cation channel in the ICCs. This channel
exhibits properties similar to that reported for TRPC channels, notably
TRPC4 (Walker et al., 2002). However, slow waves in intestinal smooth
muscle remain unchanged in TRPC4 knockout mice (Lee et al., 2005).
Thus, there is no conclusive evidence that TRPC channels, notably
TRPC4, play a physiological role in the pacemaker activity of ICCs.
In contrast, distinct TRPC channels have been shown to operate as
downstream transducers (effectors) of stimulated GPCRs such as
muscarinic acetylcholine receptors. This mechanism has been sug-
gested to apply to TRPC4, TRPC5 and TRPC6 which are activated by
cholinergic stimulation of ICCs and smooth muscle in the murine
stomach and intestine (Lee et al., 2003, 2005; Kim et al., 2006, 2007;
Tsvilovskyy et al., 2009). Based on electrophysiological and pharma-
cological similarities, both TRPC4 (Lee et al., 2005) and TRPC5 (Lee et
al., 2003) have originally been proposed to mediate the nonselective
cation current evoked by carbachol in the murine stomach. A role of
TRPC4 has been ﬁrmly established by the ﬁnding that the nonselective
cation current evoked by muscarinic receptor stimulation is abolished
by genetic deletion of TRPC4 (Lee et al., 2005; Kim et al., 2006).
Further studies using both TRPC4 and TRPC6 knockout mice
indicate that TRPC4 underlies more than 80% of the muscarinic
receptor-induced cation current in intestinal smooth muscle, while
the residual current is mediated by TRPC6 (Tsvilovskyy et al., 2009).
Following TRPC4 knockout, the carbachol-induced membrane depo-
larization and the atropine-sensitive contraction elicited by acetyl-
choline release from excitatory motor neurons are inhibited, these
effects being aggravated by additional deletion of TRPC6. In addition,
intestinal transit is slowed down in mice lacking TRPC4 and TRPC6
(Tsvilovskyy et al., 2009). From these studies it is evident that TRPC4
and TRPC6 couple muscarinic acetylcholine receptors to depolariza-
tion and contraction of intestinal smooth muscle. This is true for both
M2 and M3 muscarinic receptors which use different second
messenger mechanisms owing to their coupling to Gi/o and Gq/11
signaling pathways, respectively (Tsvilovskyy et al., 2009).2.11.3. Association of TRPC6 with gastrointestinal disease
An implication of TRPC6 in human GI motor control is exempliﬁed
by the observation that a single nucleotide polymorphism in the
promoter region of the TRPC6 gene and amissense variant in exon 4 of
the TRPC6 gene may contribute to infantile hypertrophic pyloric
stenosis (Everett et al., in press). TRPC6 appears to have a role in
cancer development, given that there is a marked upregulation of
TRPC6 expression in esophageal squamous cell carcinoma (Shi et al.,
2009) and in epithelial cells of human gastric cancers (Cai et al., 2009).
2.11.4. Therapeutic potential of TRPC blockers in the digestive system
Cholinergic contraction of smooth muscle is a key determinant of
GI motility. Recognition that TRPC4 and, to a minor degree, TRPC6 are
transducers of the depolarizing action of M2 and M3 muscarinic
acetylcholine receptors in GI smooth muscle raises the possibility to
attenuate cholinergic motor effects while sparing other cholinergi-
cally controlled tissue functions. This opportunity would be particu-
larly useful if pathological hypermotility in the GI tract is shown to be
due to exaggerated TRPC4 and TRPC6 transduction (Ambudkar, 2009).
Blockade of TRPC1 and TRPC6 also holds considerable potential in
GI oncology, given that TRPC1 may promote pancreatic cancer cell
invasion (Dong H. et al., 2010) and TRPC6 seems to play a signiﬁcant
role in human esophageal and gastric cancer development (Cai et al.,
2009; Shi et al., 2009).
3. Conclusions
Distinct TRP channels have emerged as pleiotropic signal trans-
ducers in the digestive tract. They play physiological roles in taste,
chemo- and mechanosensation, thermoregulation, pain and hyper-
algesia, epithelial cell function and homeostasis, control of motility by
neurons, ICCs and muscle cells, vascular function, and cancer
development (Fig. 2). While the implications of some TRP channels,
notably TRPA1, TRPC4, TRPM5, TRPM6, TRPM7, TRPV1, TRPV4, and
TRPV6, have been elucidated to a considerable degree, the relevance
of other TRP channels to digestive function awaits to be explored. The
polymodal chemo- and mechanosensory function of TRPA1, TRPM5,
TRPV1 and TRPV4 is of particular pathophysiological relevance, but
there are several other aspects of GI function that are under the critical
control of TRP channels, such as Ca2+ and Mg2+ absorption,
transduction of muscarinic acetylcholine receptor activation to
smooth muscle contraction, and cancer development (Fig. 2).
TRP channels in the digestive system can operate (1) as molecular
sensors (detectors or primary transducers) of chemical and physical
stimuli, (2) as downstream or secondary transducers (or effectors) of
cell activation induced by GPCRs, receptor tyrosine kinases or ion
channels, and (3) as ion transport channels (Fig. 1). While some TRP
channels operate only in one of these capacities, other TRP channels
can act both as primary and secondary transducers. This dual role is
seen with TRPA1, TRPV1 and TRPV4 which, on the one hand, are
detectors of thermal, chemical and mechanical stimuli and, on the
other hand,mediate cell responses to other stimuli, notably distension
and proinﬂammatorymediators (Blackshaw et al., 2010). A secondary
transducer role is also typical of TRPM5 in its taste function and of
TRPC4 in its role to transduce acetylcholine-evoked contraction.
Pathophysiologically, TRP channels participate in many distur-
bances of GI function (Fig. 3). Changes in TRP channel expression and
function are associated with GI inﬂammation, hyperalgesia and other
disease identities, some of which are due to speciﬁc TRP channelo-
pathies (Nilius et al., 2007). These implications have raised enormous
interest in the therapeutic exploitation of TRP channels as new drug
targets in GI disease. As a result, extensive drug development
programs have been initiated, especially with regard to TRPV1,
TRPA1 and TRPV4 channel blockers (Gharat & Szallasi, 2008;
Gunthorpe & Szallasi, 2008; Kym et al., 2009; Vincent et al., 2009;
Wong & Gavva, 2009; Baraldi et al., 2010; Voight & Kort, 2010). Fig. 4
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antagonists in the management of GI diseases and disorders. While
the results of many preclinical tests involving TRP channel agonism,
antagonism, knockdown or knockout nourish these expectations,
clinical proof-of-concept data are not yet available, except for TRPV1
desensitization strategies. In the absence of conclusive information it
is not possible to predict which TRP channels are the most promising
drug targets. The translation from the preclinical validation to the
clinical application of TRP channel-directed drugs is liable to meet
many obstacles (Hicks, 2006; Storr, 2007; Holzer, 2008a, 2008b;
Wong & Gavva, 2009), given that TRP channels are widely distributed
throughout the body and play many important physiological roles
within and outside the GI system (Wu et al., 2010). The challenge,
therefore, is to design TRP channel-directed drugs with a pharmaco-
logical proﬁle that limits their action to the alimentary canal and
speciﬁcally addresses the pathological functions of TRP channels
while the physiological implications are spared (Holzer, 2008b).Acknowledgments
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